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ABSTRACT	
Ever	 since	 the	 discovery	 of	 the	 role	 of	 DNA	 as	 the	 template	 for	 protein	 synthesis,	
efforts	have	been	made	to	develop	DNA	targeted	drugs.	One	of	the	major	challenges	in	
the	 design	 of	 DNA	 binding	 drugs	 is	 to	 achieve	 selective	 binding	 to	 specific	 DNA	
sequences,	 which	 is	 crucial	 to	 avoid	 side	 effects.	 In	 this	 thesis,	 the	 relationship	
between	molecular	 structure	 and	DNA	binding	properties	 for	 a	 group	of	 ruthenium	
complexes	 is	 investigated	with	 focus	on	sequence	 selectivity	and	binding	affinity.	 In	
particular,	 threading	 intercalation,	 an	 unusual	 DNA	 binding	 mode	 sometimes	
observed	for	dumbbell	shaped	molecules,	is	examined.	The	study	is	motivated	by	the	
fact	that	threading	intercalating	binuclear	ruthenium	complexes	previously	have	been	
shown	to	bind	selectively	to	long	stretches	of	AT‐base	pairs,	which	potentially	can	be	
used	to	target	parasites	with	high	AT‐content	in	their	genomes.	The	dissociation	from	
DNA	 is	 also	 very	 slow,	 which	 is	 a	 property	 thought	 to	 be	 important	 for	 biological	
activity.	
	
In	 this	 thesis,	 it	 is	demonstrated	by	spectroscopic	DNA	binding	studies	on	 four	new	
binuclear	complexes	 that	 threading	 intercalating	ability	 is	very	sensitive	 to	bridging	
ligand	 structure.	The	presence	of	 a	dppz‐moiety	 is	 important	 for	 threading	 to	occur	
and	 increased	 flexibility	 is	 not	 beneficial	 for	 this	 type	 of	 binding.	 Shortening	 of	 the	
bridging	ligand	increases	the	AT‐selectivity	but	reduces	the	binding	constant.	Further,	
it	is	demonstrated	that	the	enantioselectivity	is	different	for	the	two	DNA	grooves.	A	
new	mononuclear	threading	intercalating	complex	with	aryl	substituents	on	the	dppz‐
ligand	 is	 presented,	 for	 which	 it	 is	 shown	 that	 reduced	 complex	 charge	 can	 be	
compensated	 for	 by	 structural	 variations	 to	maintain	 slow	 dissociation.	 Altogether,	
three	new	threading	intercalators	have	been	developed.	From	calorimetric	studies	on	
non‐threading	 mononuclear	 complexes	 it	 is	 evident	 that	 cooperativity	 effects	 have	
large	 influence	 on	 binding	 to	 AT‐DNA.	 Those	 effects	 are	 probably	 present	 also	 for	
threading	 intercalating	 binuclear	 complexes	 and	 may	 explain	 some	 of	 the	
observations	 made	 for	 such	 complexes.	 Finally,	 cell	 studies	 show	 that	 threading	
intercalation	is	possible	also	in	the	intracellular	milieu	and	that	binuclear	complexes	
are	 internalized	 in	 live	 CHO‐K1	 cells,	 though	 endosomal	 escape	may	 be	 a	 potential	
problem	for	biological	applications.		
	
KEYWORDS:	 ruthenium,	 DNA,	 threading	 intercalation,	 sequence	 selectivity,	
enantioselectivity,	kinetics,	spectroscopy,	cell	studies,	calorimetry	
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All	living	species,	from	small	bacteria	and	parasites	to	higher	order	organisms	such	
as	humans,	share	one	common	thing:	they	all	consist	of	cells.	Cells	are	membrane	
enclosed	 self‐replicating	 entities,	 which	 lodge	 a	 complex	 machinery	 of	 macro‐
molecules	 that	 every	 day	 performs	 billions	 of	 chemical	 reactions	 in	 order	 to	
maintain	the	well‐being	of	the	organism.	One	of	the	main	components	in	the	cell	is	
deoxyribonucleic	acid,	DNA,	which	stores	the	genetic	information	and	serves	as	a	
template	for	protein	production.	The	DNA	molecule	is	a	long	chain	of	four	different	
building	 blocks,	 the	 nucleobases	 adenine,	 thymine,	 guanine	 and	 cytosine.	 The	
order	of	 the	bases	along	 the	DNA	chain	constitutes	 the	genetic	 code,	where	each	
combination	of	 three	consecutive	bases	corresponds	 to	a	specific	amino	acid,	 the	
amino	acids	being	the	units	building	up	the	proteins.	Hence,	the	order	of	bases	in	
the	 genome	 determines	 the	 order	 of	 amino	 acids	 in	 the	 proteins,	 and	 as	 a	
consequence,	 errors	 in	 the	 sequence	 of	 nucleobases	 may	 result	 in	 erroneous	
proteins.	As	the	proteins	are	responsible	for	the	majority	of	the	vital	 functions	in	
the	 cell,	 such	 as	 signaling,	 regulation,	 transportation,	 catalysis,	 structure	 and	
movement,	malfunctioning	proteins	may	 cause	 severe	damage	 to	 the	 cells	which	
may	lead	to	diseases	or	even	death	of	the	organism.	
	
Proteins,	 both	 human	 and	 bacterial,	 are	 the	main	 drug	 targets	 in	 the	 search	 for	
new	therapeutical	agents.	This	is	due	to	their	crucial	role	in	the	cell	machinery,	but	
also	the	fact	that	the	activity	of	many	proteins	can	specifically	be	either	enhanced	
or	suppressed	by	binding	of	small	synthetic	molecules	to	them.1	The	discovery	of	
the	role	of	DNA	as	a	template	for	protein	synthesis	has	increased	the	interest	for	
DNA	as	a	potential	drug	target.2‐3	Instead	of	trying	to	alter	the	activity	of	already	
existing	proteins,	the	idea	is	to	regulate	the	production	of	them	by	binding	of	small	
molecules	 to	 the	 protein	 encoding	 genes.	 The	 genome	 sequencing	 projects	 have	
enabled	 assignment	 of	 genes	 and	 regulatory	 sequences	 in	 both	 human	DNA4	 as	
well	 as	 the	 genomes	 of	 other	 organisms,	 thus	 providing	 insight	 regarding	what	
DNA	sequences	that	might	be	interesting	to	target.	However,	this	information	is	of	
little	 use	 as	 long	 as	 the	 mechanisms	 behind	 specific	 DNA	 binding	 are	 poorly	
understood.	 Although	 the	 double	 helical	 structure	 of	 DNA	 was	 proposed	 by	
Watson	and	Crick	already	 in	1953,5	 and	 the	DNA	molecule	 itself	 as	well	 as	DNA	
binding	 drugs	 have	 been	 extensively	 studied	 since,	 the	 problem	 to	 achieve	
sequence	 specific	 binding	 still	 remains	 as	 one	 of	 the	 major	 challenges	 in	 the	
development	of	DNA	targeting	drugs.	
	
1 INTRODUCTION
2 
 
Threading	intercalation	is	an	unusual	DNA	binding	mode,	in	which	part	of	the	drug	
molecule	has	 to	be	 threaded	 through	 the	base	pair	 stack	 for	binding	 to	occur.6‐8	
This	 results	 in	extremely	slow	kinetics	 for	 the	 interaction	as	well	 as	 the	binding	
being	selective	towards	flexible	DNA	structures	such	as	long	stretches	of	AT‐base	
pairs.9	Consequently,	threading	intercalating	compounds	are	interesting	as	model	
compounds	 for	 DNA	 targeting	 drugs,	 and	 a	 better	 understanding	 of	 the	
mechanisms	behind	this	type	of	binding	mode	would	be	valuable	for	future	design	
of	 new	 drugs	with	 slow	 dissociation	 and	 improved	 sequence	 selectivity.	 In	 this	
thesis,	 the	DNA	binding	properties	of	 several	different	ruthenium	complexes	are	
investigated.	 The	 aim	 is	 to	 elucidate	 how	 threading	 intercalation	 ability	 and	
selectivity	is	affected,	and	hopefully	can	be	controlled,	by	structural	variations	of	
the	 compounds.	 The	 studies	 may	 also	 lead	 to	 insights	 regarding	 how	 different	
types	of	DNA	behave	in	the	interaction	with	drug	molecules.	Finally,	results	from	
cell	 studies	 on	 binuclear	 ruthenium	 complexes	 are	 discussed	 in	 an	 attempt	 to	
evaluate	the	biological	relevance	of	the	DNA	binding	studies	and	the	potential	use	
of	binuclear	ruthenium	complexes	for	biomedical	applications.	
	
In	 the	 following	 chapters,	 a	more	 detailed	 background	 to	 the	work	 as	well	 as	 a	
brief	 description	 of	 the	 experimental	 methods	 and	 some	 fundamental	 concepts	
will	be	given,	before	the	main	results	are	presented.		
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The	 main	 theme	 in	 this	 thesis	 is	 interactions	 between	 synthetic	 molecules	 and	
DNA,	with	special	attention	on	the	DNA	binding	mode	threading	intercalation.	This	
chapter	aims	to	explain	how	and	why	DNA	can	be	exploited	as	a	drug	target	and	
gives	an	 introduction	 to	 the	most	 fundamental	aspects	of	drug‐DNA	 interactions.	
The	 main	 characteristics	 of	 threading	 intercalation	 are	 also	 described	 and	 the	
choice	 of	 ruthenium	 complexes	 as	 model	 compounds	 for	 this	 type	 of	 DNA	
interaction	is	motivated.		
2.1 Structure	and	Function	of	Nucleic	Acids	
Deoxyribonucleic	acid	(DNA)	is	a	double	stranded,	right‐handed	helical	structure,	
where	 the	 two	 strands	 are	 polymers	 built	 up	 from	 four	 different	 units,	 the	
nucleotides.	 Each	 nucleotide	 consists	 of	 phosphoric	 acid	 esterified	 with	 a	
deoxyribose	 sugar	 that	 forms	 the	 repetitive	 unit	 of	 the	 polymer	 backbone,	 and,	
attached	to	the	deoxyribose	group,	one	of	the	four	bases	adenine	(A),	guanine	(G),	
thymine	 (T)	 or	 cytosine	 (C)	 (Figure	 2.1).	 The	 two‐ring	 bases	 A	 and	 G	 are	
commonly	referred	to	as	purines,	whereas	the	one‐ring	bases	T	and	C	are	known	
as	 pyrimidines.	 In	 the	 closely	 related	 ribonucleic	 acid	 (RNA),	 which	 is	 usually	
single	 stranded,	 the	 sugar	 is	 ribose	 that	 carries	 one	 extra	 hydroxyl	 group	
compared	with	deoxyribose,	and	the	methyl	group	is	missing	on	thymine.5,	10		
	
At	 physiological	 pH,	 the	 phosphate	 groups	 in	 the	 backbone	 of	 the	 DNA	 double	
helix	 are	 negatively	 charged	 while	 the	 surface	 of	 the	 base	 pairs	 is	 quite	
hydrophobic.	As	a	result	of	the	hydrophobic	effect,	the	base	pairs	stack	on	top	of	
each	 other	 with	 the	 bases	 pointing	 towards	 the	 center	 of	 the	 helix	 and	 the	
backbone	positioned	on	 the	outside	 facing	 the	surrounding	water.	 In	addition	 to	
the	hydrophobic	effect,	 the	 two	strands	of	 the	double	helix	are	held	 together	by	
hydrogen	bonds	between	 the	bases,	where	A	always	pairs	with	T,	 and	G	with	C.	
This	specific	hydrogen	bonding	pattern,	also	referred	to	as	base	pairing,	results	in	
the	two	strands	being	complementary	to	each	other,	and	accounts	for	the	storage	
and	 replication	 of	 the	 genetic	 information.	 As	 seen	 in	 Figure	 2.1,	 only	 two	
hydrogen	bonds	are	 formed	between	A	and	T	compared	with	 three	 for	G	and	C,	
resulting	 in	 the	AT‐base	pairs	being	 less	 stable,	 and	 thus	more	 flexible,	 than	 the	
GC‐base	 pairs.	 Although	 RNA	 mainly	 exists	 as	 single	 stranded	 molecules,	 the	
strands	often	 folds	 into	 three‐dimensional	structures	with	duplex	regions	where	
base	pairing	occurs.	RNA	can	also	base	pair	with	single	stranded	DNA,	which	is	of	
great	importance	for	the	production	of	proteins	as	described	below.5,	10						
2 BACKGROUND
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Figure	 2.1.	 Structure	 of	 the	 nucleotides	 and	 the	 sugar‐phosphate	 backbone	 in	 a	
dinucleotide	duplex.	
	
Double	helical	nucleic	acids	can	exist	in	three	different	conformations:	A‐,	B‐	and	Z‐
form	(Figure	2.2).	All	three	forms	are	found	in	biological	systems,	though	for	DNA	
the	B‐form	is	by	far	the	most	abundant.	Between	the	backbones	of	the	two	strands	
there	are	two	grooves,	one	on	each	side	of	the	base	pair	stack,	which	in	the	B‐form	
have	 equal	 depths	 but	 different	 widths;	 the	major	 groove,	 as	 the	 name	 implies,	
being	wider	 than	 the	minor	groove.	 In	A‐DNA	 the	bases	are	 somewhat	displaced	
from	the	center	of	the	helix	and	the	base	pairs	are	inclined	at	a	large	angle	relative	
the	helix	axis,	 resulting	 in	a	deep	and	narrow	major	groove	and	a	shallow	minor	
groove.	This	conformation	is	mainly	observed	for	double	stranded	RNA	and	DNA‐
RNA	 duplexes,	 but	 also	 occurs	 in	 double	 stranded	 DNA	 at	 short	 stretches	 of	
sequential	purines	or	as	a	result	of	dehydration	or	protein	binding.	Z‐DNA	is	a	left‐
handed	 structure	 that	 is	 observed	 for	 long	 alternating	 purine‐pyrimidine	
sequences,	mainly	GC.10‐11	 In	addition	 to	 the	above	mentioned	duplex	 structures,	
there	 are	 regions	 in	 the	DNA	where	 the	duplex	 structure	 is	 perturbed.	Hairpins,	
loops	 and	 bulges	 are	 all	 structures	 that	 contain	 unpaired	 bases,	 and	while	 they	
play	an	important	role	for	RNA	structure	and	function,	they	mainly	arise	in	natural	
DNA	as	a	result	of	mutations	on	one	of	the	DNA	strands.10	
	
Before	cell	division	occurs,	 the	DNA	 is	duplicated	 to	provide	both	daughter	cells	
with	a	complete	set	of	the	genetic	information,	a	process	referred	to	as	replication.	
During	 replication,	 the	 two	 strands	 of	 the	 double	 helix	 are	 separated	 from	each	
other,	 and	 new	 DNA	 strands	 are	 synthesized	 along	 each	 of	 the	 single	 strands,	
which	 act	 as	 templates	 for	 the	 synthesis.	 Nucleotides	 are	 added	 to	 the	 growing	
strands	 by	 a	 protein	 called	 polymerase,	 but	 only	 nucleotides	 that	 are	 correctly	
base	 paired	 with	 a	 nucleobase	 on	 the	 template	 strand	 are	 incorporated	 in	 the	
growing	 strand.	 Hence,	 the	 newly	 synthesized	 strand	will	 be	 complementary	 to
5 
 
	
Figure	2.2.	 Left:	A‐	B‐	 and	 Z‐form	 of	a	16	 base	 pair	DNA‐duplex,	 sideview	 (top)	and	
topview	 (bottom).	 Right:	 schematic	 picture	 of	 non‐duplex	 structures.	 From	 top	 to	
bottom:	mismatch,	bulge,	internal	loop	and	hairpin	loop.		
	
the	template	strand,	and	the	genetic	information	will	be	maintained.	The	first	step	
in	 protein	 synthesis,	 transcription	 of	 the	 information	 stored	 in	 the	 gene	 into	
messenger	RNA,	is	very	similar	to	replication:	the	two	DNA	strands	are	separated	
from	 each	 other	 and	 one	 of	 them	 serves	 as	 a	 template	 for	 synthesis	 of	 a	
complementary	strand	of	RNA.	The	RNA	is	then	translated	by	the	ribosomes	into	a	
long	 chain	 of	 amino	 acids,	 a	 polypeptide	 chain,	 that	 folds	 itself	 into	 a	 three	
dimensional	 structure	 that	 forms	 the	 functional	 protein.	 Both	 replication	 and	
transcription	 requires	 binding	 of	 a	 number	 of	 proteins,	 such	 as	 the	 polymerase	
and	 various	 transcription	 factors,	 to	 the	 DNA.12	 If	 the	 assembly	 of	 the	
replication/transcription	proteins	on	the	DNA	is	inhibited,	e.g.	by	binding	of	small	
drug	molecules	to	the	DNA,	cell	division	and	protein	synthesis	can	no	longer	occur.	
Thus,	 DNA	 is	 interesting	 as	 a	 drug	 target	 for	 diseases	 where	 cell	 proliferation	
needs	to	be	inhibited,	such	as	cancer	or	bacterial	infections,	or	diseases	caused	by	
protein	 overproduction.13	 In	 theory,	 it	 should	 be	 possible	 to	 also	 enhance	 the	
production	 of	 a	 specific	 protein	 if	 the	 bound	 drug	 attracts	 the	 transcription	
machinery	 to	 the	 DNA,	 but	 efforts	 to	 mimic	 transcription	 factors	 with	 small	
peptide	containing	synthetic	molecules	has	proven	this	to	be	far	more	difficult.14	
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2.2 DNA	as	a	Drug	Target	
Compared	 to	 proteins,	 where	 the	 drug	 usually	 binds	 to	 a	 specific	 motif	 of	
hydrogen	bonds	and	hydrophobic	patches	that	is	unique	to	each	protein,	DNA	is	a	
quite	 uniform	 structure.	 The	 DNA	 helix	 does	 not	 fold	 into	 a	 three	 dimensional	
structure	in	the	same	way	as	the	polypeptide	chains	of	proteins	do,	thus	providing	
few	 means	 to	 distinguish	 different	 sequences	 from	 each	 other.	 Ever	 since	 the	
discovery	of	the	duplex	structure	by	Watson	and	Crick,	efforts	have	been	made	to	
correlate	 DNA	 structure	 with	 sequence,	 but	 with	 little	 success	 because	 the	
structural	differences	between	the	base	pairs	are	miniscule.15	The	different	duplex	
and	non‐duplex	structures	mentioned	above	may	serve	as	a	 tool	 for	recognition,	
but	as	they	are	not	gene	specific	they	cannot	alone	act	as	the	recognition	pattern	
for	a	drug.	The	most	promising	strategy	 to	 target	specific	DNA	sequences	so	 far,	
seems	to	be	to	exploit	the	base	pair	sequence.	
	
Although	 covalent	 binding	 of	 drugs	 to	 the	DNA	 is	 an	 excellent	way	 of	 inhibiting	
DNA	 related	 processes,	 as	 seen	 for	 example	 by	 the	 successful	 use	 of	 DNA‐
alkylating	anti‐cancer	drugs,16‐18	covalent	interactions	are	not	as	efficient	when	it	
comes	to	recognition	of	specific	genes.	In	order	to	target	a	specific	gene	the	drug	
has	to	interact	with	a	relatively	large	fragment	of	the	DNA	(13‐17	base	pairs17,	19‐
20),	and	here	non‐covalent	 interactions	play	an	 important	role.	 In	addition	to	the	
electrostatic	 interaction	 between	 positively	 charged	 ions	 and	 the	 negatively	
charged	DNA,	 there	 are	 two	major	modes	 of	 non‐covalent	 DNA	 binding:	 groove	
binding	and	intercalation.10	Groove	binding	can	occur	in	either	of	the	two	grooves,	
with	the	major	groove	being	mainly	the	site	 for	protein	binding	due	to	 its	 larger	
size.14	 Typical	 synthetic	 groove	 binding	 drugs	 are	 small	 crescent‐shaped	
molecules	 that	 interact	with	 the	minor	 groove	 via	 hydrogen	 bonds	 and	 van	 der	
Waals	interactions.	Intercalation	refers	to	the	insertion	of	a	molecule	or	part	of	a	
molecule,	 usually	 a	 flat	 heteroaromatic	 polycyclic	 ring	 system,	 between	 two	
adjacent	base	pairs,	where	 it	 interacts	with	 the	bases	by	‐stacking.21	Generally,	
groove	 binding	 occurs	without	major	 distortions	 of	 the	DNA	 structure,	whereas	
intercalation	results	in	lengthening	and	unwinding	of	the	DNA	which	is	associated	
with	a	significant	cost	 in	 free	energy	that	has	to	be	compensated	for	by	superior	
hydrophobic	 interactions.	 It	 should	 be	 noted	 that	many	 DNA	 intercalators	 have	
side	 groups	 that	 interact	 with	 the	 grooves	 upon	 binding,	 sometimes	 making	 it	
difficult	to	clearly	distinguish	between	groove	binders	and	intercalators.		
		
The	sequence	selectivity	of	DNA	intercalators	is	generally	rather	poor	because	the	
drug	only	 interacts	with	the	two	base	pairs	 forming	the	intercalation	pocket	and	
sequence	has	little	influence	on	the	intercalation	pocket	itself.	Groove	binders,	on	
the	other	hand,	are	much	more	promising	as	sequence	specific	DNA	binding	drugs	
as	both	grooves	display	a	sequence	specific	pattern	of	functional	groups	that	can	
be	used	for	recognition.	In	the	major	groove,	all	four	possible	combinations	of	base	
pairs	 display	 different	 hydrogen	 bonding	 capabilities,	 whereas	 in	 the	 minor	
groove	AT	and	TA	base	pairs	have	 identical	properties.14,	 22‐23	The	perhaps	most	
obvious	 way	 to	 achieve	 specific	 binding	 in	 the	 major	 groove	 is	 to	 use	 short	
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oligonucleotides	 that	 bind	 to	purines	via	Hoogsteen	base	pairing	 forming	 triple‐
helix	structures.	However,	the	fact	that	the	target	sequence	must	contain	several	
consecutive	 purines	 on	 the	 same	 strand,	 combined	with	 the	 chemical	 instability	
and	 poor	 membrane	 permeability	 of	 oligonucleotides,	 limit	 their	 therapeutical	
use.3,	 14,	 23	 Dervan	 and	 co‐workers	 have	 developed	 double	 stranded	 crescent	
shaped	hairpin	polyamides,	 consisting	 of	 pyrrole,	 hydroxypyrrole	 and	 imidazole	
units	 connected	via	peptide	bonds,	which	 can	 recognize	all	 four	base	pairs	 from	
the	minor	groove	by	a	combination	of	hydrogen	bonds	and	sterical	interactions.23‐
24	DNA	sequences	as	 long	as	16	base	pairs	have	been	selectively	targeted	by	this	
method,20	 and	 the	 polyamides	 have	 been	 shown	 to	 inhibit	 viral	 replication	 in	
human	 cells	 by	 preventing	minor	 groove	 binding	 transcription	 factors	 to	 access	
the	 DNA.25‐26	 Although	 this	 is	 a	 very	 promising	 strategy	 to	 design	 gene	 specific	
DNA	binding	 drugs,	 it	 is	 limited	 by	 the	 fact	 that	 the	 polyamides	 bind	 the	minor	
groove	 while	 the	 majority	 of	 DNA‐protein	 interactions	 occur	 in	 the	 major	
groove.14	 The	 polyamides	 can	 however	 be	 used	 to	 guide	 chemotherapeutics	 of	
poor	selectivity	to	a	specific	gene.27		
	
Due	to	the	difficulties	to	target	specific	genes,	DNA	binding	drugs	are	still	a	rarity	
among	 commercially	 available	 pharmaceutics.1	 Only	 in	 the	 treatment	 of	 cancer,	
where	the	aim	is	to	kill	the	tumor	cells,	have	DNA	binding	drugs	found	widespread	
use.17‐18,	 28	Anti‐cancer	drugs	generally	bind	unspecifically	 to	 the	whole	genome,	
and	discrimination	between	healthy	and	tumor	cells	occurs	by	other	mechanisms,	
such	as	differences	in	cellular	uptake	of	the	drug.17‐18	The	selectivity	is	still	poor,	
though,	and	cancer	chemotherapy	is	normally	associated	with	severe	side	effects.	
There	are	examples	of	DNA	binding	drugs	that	display	antibacterial,	antifungal	or	
antimalarial	 effects	 that	 are/could	 be	 of	 therapeutical	 use,29	 but	 also	 for	 these	
drugs	 selectivity	 occurs	 on	 cell	 rather	 than	 gene	 level.	 For	 example,	 the	 AT‐
selective	 drugs	 pentamidine,	 berenil	 and	 furamidine	 are	 active	 against	 diseases	
caused	 by	 protozoan	 parasites,	 where	 one	 proposed	 mechanism	 of	 action	 is	
binding	of	the	drugs	to	kinetoplasts,	i.e.	AT‐rich	circular	DNA	found	in	the	parasite	
mitochondria.30‐31		
2.3 Threading	Intercalation	
In	 addition	 to	 the	 common	 non‐covalent	 DNA	 binding	modes,	 intercalation	 and	
groove	 binding,	 there	 is	 a	 third	 one	 termed	 threading	 intercalation,	 which	
combines	 intercalation	 with	 interactions	 in	 the	 grooves.	 The	 typical	 threading	
intercalator	is	a	flat	heterocyclic	aromatic	molecule	with	bulky,	and	very	often	also	
charged,	 substituents	 in	 both	 ends.	 As	 the	 name	 implies,	 one	 of	 the	 bulky	
substituents	has	to	be	threaded	through	the	base	pair	stack	for	intercalation	of	the	
flat	 middle	 part	 to	 occur,	 resulting	 in	 the	 bulky	 substituents	 being	 located	 in	
opposite	grooves	in	the	bound	state	(Figure	2.3).	The	threading	process	requires	
large	 distortions	 of	 the	 DNA	 structure,	 in	 some	 cases	 even	 transient	 base	 pair	
opening,8,	 32	resulting	in	both	threading	and	dissociation	from	the	threaded	state	
being	 extremely	 slow	 processes.6‐7,	 33	 Several	 intercalating	 units	 can	 also	 be
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Figure	 2.3.	 Schematic	 picture	 of	 threading	 intercalation	 (left)	 and	 polyintercalation	
(right).	Both	types	of	binding	modes	require	threading	of	bulky	groups	through	the	base	
pair	stack.	
	
connected	via	 flexible	 linkers	to	create	poly‐intercalators	 that	 thread	the	DNA	 in	
order	to	insert	all	their	intercalating	units	in	the	base	pair	stack.34‐38	
	
Threading	 intercalation	 was	 first	 discovered	 for	 the	 natural	 antibiotic	
nogalamycin,	whose	cytotoxic	activity	was	assigned	to	the	slow	dissociation	from	
DNA.6‐8,	 39‐40	 As	 there	 appears	 to	 be	 a	 correlation	 between	 slow	 dissociation	
kinetics	and	cytotoxicity,7,	41‐43		threading	intercalating	compounds	are	interesting	
as	potential	DNA	targeting	drugs,	and	efforts	have	been	made	to	develop	synthetic	
threading	 intercalators.33,	 44‐57	Figure	2.4	shows	examples	of	molecules	that	have	
been	shown	to	bind	DNA	by	threading	intercalation.	None	of	them	displays	as	slow	
kinetics	as	nogalamycin,	but	focus	has	instead	been	on	targeting	specific	DNA	and	
RNA	 structures.	 Many	 threading	 intercalators	 bind	 selectively	 to	 DNA	 and	 RNA	
bulges	 and	 loops	 since	 such	 structures	 already	 contain	 a	 “loophole”	 where	 the	
bulky	substituent	more	easily	can	pass	 through	the	base	pair	stack.50‐53,	 58	There	
are	also	examples	of	threading	intercalators	that	target	quadruplex	structures.54‐55	
Further,	 a	 poly‐intercalator	 containing	 sequence	 specific	 peptide	 links	 has	 been	
reported	 to	 selectively	 target	 a	 14	 bp	 long	 DNA	 fragment	 with	 extremely	 slow	
dissociation	compared	with	corresponding	monomeric	threading	intercalators.37	
2.4 Why	Ruthenium	Complexes?		
Since	 Barton’s	 pioneering	 DNA	 binding	 studies	 on	 [Ru(phen)3]2+	 in	 the	 mid	
1980’s,59	 this	 and	 related	 ruthenium	 polypyridyl	 complexes	 have	 received	
considerable	interest	as	probes	for	DNA,	arising	from	the	possibility	to	synthesize	
stable	complexes	where	the	emission	properties	can	be	fine‐tuned	by	varying	the	
ligands.60‐62	 Over	 the	 years,	 numerous	 complexes	 have	 been	 designed	 for	 this	
purpose,	 the	 perhaps	 most	 well‐known	 being	 the	 light‐switch	 complexes	
[Ru(phen)2dppz]2+	 and	 [Ru(bpy)2dppz]2+,	 which	 are	 completely	 quenched	 in	
aqueous	solution	but	become	brightly	luminescent	upon	intercalation	into	DNA.63‐
64	 Recently,	 focus	 has	 shifted	 somewhat	 to	 also	 include	 more	 biomedical
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Figure	2.4.	Examples	of	different	types	of	threading	intercalators.	Compound	names	are	
written	in	italic	whereas	classes	of	compounds	are	labeled	in	regular	font.	
	
applications.	 There	 are	 examples	 in	 the	 literature	 of	 ruthenium	 complexes	 that	
selectively	 target	 different	 DNA	 and	 RNA	 bulge	 structures,65	 display	 cytotoxic	
activity,66‐67	 compact	 DNA,68‐69	 and	 stain	 various	 cellular	 components,70‐72	 with	
potential	 use	 as	 diagnostic	 probes,	 anti‐cancer	 drugs,	 gene	 delivery	 vectors	 and	
imaging	agents,	respectively.	
Even	 if	 threading	 bisintercalation	 of	 the	 flexibly	 linked	 dimer	 [‐C4(cpdppz)2‐
(phen)4Ru2]4+	 was	 demonstrated	 1999,35‐36	 it	 was	 quite	 a	 surprise	 when	 it	 was	
serendipitously	 discovered	 in	 2002	 that	 the	 binuclear	 ruthenium	 complex	 [‐
bidppz(phen)4Ru2]4+	 binds	 DNA	 by	 threading	 intercalation.73	 The	 DNA	 inter‐
actions	of	this	complex	and	its	bipyridine	homologue	have	since	been	intensively	
studied	 as	 these	 complexes	 possess	 a	 number	 of	 properties	 that	 make	 them	
suitable	as	a	model	compounds	in	the	quest	for	understanding	of	the	mechanisms	
behind	 threading	 intercalation.	 The	 kinetics	 is	 extremely	 slow	 compared	 with	
other	synthetic	 threading	mono‐intercalators,	with	dissociation	rate	constants	 in	
the	 same	 range	 as	 those	 for	 nogalamycin.7,	 73	 The	 slow	kinetics	 is	 important	 for	
biological	activity	as	mentioned	above,	but	also	enables	studies	of	the	initial	non‐
threading	 interactions	 with	 DNA.	 In	 combination	 with	 the	 fact	 that	 these	
complexes	also	exhibit	light‐switch	properties,73	the	slow	kinetics	makes	it	easy	to	
study	 the	 threading	 process	 by	 conventional	 spectroscopic	 techniques.	 Previous	
studies	have	mainly	been	focused	on	characterization	of	the	threading	mechanism	
and	kinetics,74‐76	as	well	as	the	selectivity	for	various	DNA	targets.9,	77‐78	The	latter	
resulted	 in	 the	 discovery	 that	 threading	 of	 the	 complex	 is	 kinetically	 selective	
towards	 long	 (>10	bp)	 sequences	of	 alternating	AT‐base	pairs,78	 a	property	 that	
could	potentially	be	used	to	target	parasites	with	AT‐rich	genomes.30‐31,	79	Finally,	
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the	 presence	 of	 ruthenium	 ions	 facilitates	 systematic	 variations	 of	 complex	
structure,	 which	 is	 central	 to	 the	 work	 in	 this	 thesis,	 where	 focus	 is	 on	 the	
complexes	rather	than	the	DNA	targets.	The	ruthenium	(II)	ion	has	an	octahedral	
coordination	 geometry,	 which	 in	 combination	 with	 slow	 ligand	 exchange	 rates,	
enables	synthesis	of	stable	and	enantiomerically	pure	complexes	by	coordination	
of	 bidentate	 ligands	 to	 the	 ruthenium.	 The	 coordination	 of	 ruthenium	 to	 poly‐
pyridyl	 ligands	 is	 generally	 strong	 enough	 to	 allow	 harsh	 reaction	 conditions,	
which	 is	 an	 advantage	 since	 the	 ligands	 can	 be	 chemically	 modified	 also	 when	
coordinated	to	the	ruthenium.62			
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The	 DNA	 binding	 properties	 of	 several	 ruthenium	 complexes	 have	 been	
investigated	in	this	thesis.	The	DNA	binding	studies	have	mainly	been	focused	on	
evaluating	 structural	 effects	 of	 the	 intercalating	 part	 on	 threading	 intercalation	
ability	 and	 sequence	 selectivity	 of	 the	 complexes.	 This	 has	 been	 done	 by	
comparison	of	their	association	and	dissociation	rates	as	well	as	relative	binding	
constants	 to	 [poly(dAdT)]2	 (AT‐)	 and	 calf	 thymus(ct)‐DNA,	 using	 different	
spectroscopic	techniques.	Isothermal	titration	calorimetry	has	been	used	to	study	
the	 thermodynamics	 of	 the	 interactions	 between	mononuclear	 dppz	 complexes,	
the	smallest	common	unit	of	the	threading	intercalating	complexes,	and	AT‐DNA.	
Finally,	 the	uptake	and	distribution	 in	both	 live	and	 fixed	cells	has	been	 studied	
using	confocal	laser	scanning	microscopy.	Below	follows	a	brief	description	of	the	
mentioned	 techniques	 and	 some	 fundamental	 concepts,	 aiming	 to	 explain	 how	
they	were	used	 in	 this	 project	 and	how	 to	 interpret	 the	 results	 in	 the	 following	
chapter.		
3.1 Synthesis	of	Enantiopure	Ruthenium	Complexes	
Coordination	 of	 bidentate	 ligands,	 such	 as	 phenanthroline	 or	 bipyridine,	 to	
divalent	ruthenium	results	in	complexes	that	exist	in	two	enantiomeric	forms,	the	
right‐handed	 ‐form	 and	 the	 left‐handed	 ‐form	 (Figure	 3.1).	 Previous	 studies	
have	revealed	large	differences	between	the	enantiomers	in	their	interactions	with	
DNA,	 and	 therefore	 it	 is	 important	 to	 investigate	 the	 complexes	 in	 their	
enantiomerically	pure	forms.	The	synthesis	of	the	pure	enantiomers	of	the	studied	
complexes	 is	 based	 on	 the	 strategy	 developed	 by	 Lincoln	 for	 synthesis	 of	
enantiopure	[Ru(phen)2dppz]2+,	where	homochiral	[Ru(phen)2pq]2+	is	obtained	by	
resolving	 the	 racemate	 into	 the	 pure	 ‐	 and	 ‐enantiomers	 by	 repeated	
recystallization	 with	 arsenyl	 D(‐)‐	 or	 L(+)‐tartrate,	 respectively.64	 Due	 to	 the	
stability	of	bidentate	ruthenium	complexes,	the	pure	enantiomers	of	the	diquinone	
can	 then	 be	 used	 as	 starting	 material	 for	 the	 synthesis	 of	 larger	 enantiopure	
ruthenium	complexes.	
	
Since	 only	 imagination	 and	 synthetic	 skills	 set	 the	 limit	 for	 how	many	 different	
ligands	can	be	made,	and	ligands,	chirality	around	the	ruthenium	ions,	number	of	
ruthenium	 ions	etc.	 can	be	 combined	 in	a	 seemingly	 infinite	number	of	ways,	 all
3 FUNDAMENTAL	CONCEPTS	
AND	METHODOLOGY	
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Figure	3.1.	The	‐	(left)	and	‐enantiomer	(right)	of	[Ru(phen)3]2+.	
	
conceivable	 structures	 could	 impossibly	 be	 examined.	 The	 new	 complexes	 have	
been	designed	with	 the	well	 studied	 [‐bidppz(phen)4Ru2]4+	 as	model	where	 the	
intercalating	part	 has	been	 systematically	 varied.	Also,	 it	was	 important	 that	 the	
complexes	 could	 be	 obtained	 in	 relatively	 few	 reaction	 steps.	 Two	 reactions	 in	
particular	 have	 been	 central	 for	 the	 complexes	 investigated	 in	 this	 thesis:	 the	
formation	of	a	phenazine‐moiety	by	reacting	 the	diquinone	with	an	orto‐diamine	
(Scheme	 3.1)	 and	 the	 formation	 of	 an	 benzimidazole‐moiety	 by	 reacting	 the	
diquinone	with	an	aldehyde	using	ammonium	acetate	as	nitrogen	source	(Scheme	
3.2).	 By	 varying	 the	 substituents	 on	 the	 diamine	 and	 the	 aldehyde,	 all	 the	
investigated	complexes	could	be	obtained	using	these	reactions.	
3.2 Absorption	and	Emission	of	Light	
Molecules	 can	 be	 excited	 from	 their	 ground	 state	 to	 higher	 electronic	 states	 by	
interaction	with	light,	a	process	referred	to	as	absorption.	In	order	for	absorption	
to	 occur,	 the	 Bohr	 frequency	 condition	 has	 to	 be	 satisfied,	 i.e.	 the	 energy	 of	 the	
incident	light	has	to	exactly	match	the	energy	difference	between	the	ground	state	
and	 the	 excited	 state	 of	 the	 absorbing	 molecule.	 This	 is	 utilized	 in	 different	
spectroscopic	techniques	where	the	extent	of	absorption	is	measured	as	a	function	
of	 wavelength,	 i.e.	 the	 energy	 of	 the	 light.	 The	 energy	 difference	 between	 the	
ground	 state	 and	 the	 excited	 state	 depends	 not	 only	 on	 the	 structure	 of	 the	
molecule	 but	 also	 the	 environment	 around	 the	 chromophore.	 Therefore	
spectroscopic	 techniques	can	be	used	 to	probe	DNA	binding,	as	 the	environment	
around	the	chromophore	changes	when	bound	to	DNA	compared	with	when	free	
in	solution.	
	
Light	 is	composed	of	an	electric	and	a	magnetic	 field	oscillating	 in	perpendicular	
directions	relative	to	each	other	and	to	the	direction	of	propagation.	 In	order	for	
absorption	to	occur,	the	electric	field	has	to	induce	an	oscillation	in	the	electronic	
charge	distribution	of	the	chromophore.	This	oscillating	charge	distribution	gives	
rise	to	a	transition	dipole	moment,	which	for	each	transition	has	a	fixed	direction	
with	respect	to	the	molecule	structure.	The	probability	 for	absorption	to	occur	 is	
proportional	 to	 the	magnitude	 of	 the	 transition	 dipole	moment		 as	well	 as	 the
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Scheme	3.1.	Formation	of	the	phenazine‐moiety	used	in	the	synthesis	of	complex	3,	4,	P	
and	T.	
	
		
Scheme	3.2.	Formation	of	the	benzimidazole‐moiety	used	in	the	synthesis	of	complex	2	
and	3.	
	
angle	θ	between	the	transition	dipole	moment	and	the	oscillation	direction	of	the	
incoming	light:80	
	
ܣ ∝ ߤଶܿ݋ݏଶߠ		 	 	 (Equation	3.1)	
	
An	electronically	excited	molecule	can	return	to	the	ground	state	by	both	radiative	
and	non‐radiative	pathways	as	depicted	 in	 the	 Jablonski	diagram	(Figure	3.2).	 In	
contrast	 to	 absorption,	 which	 always	 occurs	 with	 conservation	 of	 spin,	 both	
radiative	 and	 non‐radiative	 relaxation	 processes	 may	 involve	 a	 change	 of	 spin.	
Internal	 conversion	 and	 intersystem	 crossing	 are	 both	 non‐radiative	 processes,	
meaning	that	no	emission	of	light	occurs	upon	relaxation.	Internal	conversion	does	
not	 involve	 a	 change	 of	 spin	 and	 can	 be	 described	 as	 a	 conversion	 of	 electronic	
energy	 into	 vibrational	 energy,	 which	 is	 then	 dissipated	 as	 heat	 to	 the	
surroundings.	 Intersystem	 crossing,	 on	 the	 other	 hand,	 is	 the	 conversion	 of	 a	
singlet	 (spin‐paired)	 excited	 electronic	 state	 to	 an	 excited	 triplet	 (unpaired)	
electronic	state	(or	vice	versa).	Such	a	transition	is	formally	forbidden	according	to	
quantum	 mechanics	 and	 hence	 very	 slow,	 but	 the	 rate	 of	 this	 process	 can	 be	
greatly	enhanced	in	presence	of	a	heavy	atom	due	to	spin‐orbit	coupling.	
	
Fluorescence	is	the	process	when	the	system	relaxes	from	an	excited	singlet	state	
to	 the	 ground	 state	 with	 concomitant	 emission	 of	 light.	 Because	 internal	
conversion	 from	 higher	 exited	 states	 to	 the	 first	 excited	 state	 is	 much	 faster	
(occurs	within	10‐12	s)	 than	emission	of	 light,	 fluorescence	generally	occurs	 from
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Figure	3.2.	 Jablonski	diagram	 illustrating	 the	 transitions	between	different	 electronic	
states.	 Solid	 and	 dashed	 arrows	 indicate	 radiative	 and	 non‐radiative	 processes,	
respectively.	
	
the	lowest	vibrational	level	of	the	first	excited	state.	The	emissive	relaxation	from	
an	excited	triplet	state	to	the	ground	state	is	termed	phosphorescence.	Because	it	
is	spin‐forbidden	it	is	a	slow	process	that	occurs	on	the	timescale	of	milliseconds	to	
seconds,	 as	 compared	with	 nanoseconds	 for	 fluorescence,	 but	 in	 resemblance	 to	
intersystem	crossing	the	rate	can	be	enhanced	by	the	presence	of	heavy	atoms.	The	
Bohr	 frequency	 condition	 has	 to	 be	 fulfilled	 also	 for	 fluorescence	 and	
phosphorescence,	and	the	emitted	light	can	thus	be	used	to	probe	the	environment	
of	the	chromphore.81	
3.3 Photophysical	Properties	of	Ruthenium	Polypyridyl	Complexes	
Absorption	 of	 light	 by	 ruthenium	 polypyridyl	 complexes	 results	 in	 a	 number	 of	
different	 excited	 singlet	 states.	 Most	 of	 them	 arises	 from	 intraligand	 	 	 *	
transitions	or	d		*	metal‐to‐ligand	charge‐transfer	(MLCT)	transitions,	where	a	
ligand		electron	or	a	metal	d	electron	is	excited	to	a	ligand	*	orbital,	respectively.	
All	 those	excited	 states	 rapidly	 and	efficiently	undergo	 intersystem	crossing	 to	 a	
state	usually	referred	to	as	the	lowest	energy	excited	triplet	state,	a	3MLCT	state,	
the	rate	and	efficiency	of	this	spin‐forbidden	process	being	greatly	enhanced	due	
to	 spin‐orbit	 coupling	with	 the	 ruthenium	 heavy	 atom.	 Relaxation	 of	 the	 3MLCT	
state	 to	 the	 singlet	 ground	 state	 via	 non‐radiative	 pathways	 is	 relatively	 slow.	
Thus,	the	excited	state	is	rather	long	lived,	allowing	relaxation	to	the	ground	state	
also	by	emission	of	light.	As	emission	occurs	from	what	is	seen	as	a	triplet	state,	it	
would	be	regarded	as	phosphorescence.	However,	 the	presence	of	the	ruthenium	
atom	 results	 in	 significant	 singlet‐triplet	 mixing	 of	 the	 electronic	 states,	 which	
means	that	the	lowest	energy	excited	state	also	have	substantial	singlet	character.	
Phosphorescence	 is	 therefore	not	 an	entirely	 correct	description	of	 the	 emission	
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which	for	example	occurs	for	example	on	much	faster	timescales	(100	ns	‐	10	s)	
than	what	 is	usually	observed	 for	phosphorescence,	 though	 it	 is	still	 slower	 than	
fluorescence.81‐83		
	
Although	 ruthenium	 complexes	 in	 general	 are	 luminescent,	 many	 ruthenium	
complexes	containing	a	dppz‐moiety	are	non‐emissive	in	water.	The	complexes	are	
still	 highly	 luminescent	 in	 non‐polar	 environments,	 though,	 and	 this	 extreme	
sensitivity	 for	 the	 surroundings	 is	 commonly	 referred	 to	 as	 the	 light‐switch	
effect.63‐64,	 84‐86	The	origin	of	 this	phenomenon	has	been	 studied	 in	detail	 for	 the	
model	 compounds	 [Ru(phen)2dppz]2+	 and	 [Ru(bpy)2dppz]2+,	 and	 it	 has	 been	
concluded	 that	 the	 emissive	 3MLCT	 state,	which	 is	 located	on	 the	dppz	 ligand,	 is	
effectively	 quenched	 in	 protic	 solvents	 by	 hydrogen	 bonding	 to	 the	 phenazine	
nitrogens	on	the	dppz	ligand.86	Olofsson	et	al.	have	shown	that	the	fully	quenched	
species	 results	 from	 hydrogen	 bonding	 to	 both	 phenazine	 nitrogens,	 whereas	
complexes	with	one	and	no	hydrogen	bonds	both	are	emissive	but	with	different	
emission	lifetimes.87	Although	addition	of	substituents	to	the	dppz	ligand	may	alter	
the	 photophysical	 properties	 of	 the	 complex,86	 the	 threading	 intercalating	
binuclear	 ruthenium	 complexes	 studied	 in	 this	 thesis	 also	 exhibit	 light‐switch	
properties.	 Thus,	 when	 the	 dppz‐moiety	 of	 these	 complexes	 is	 intercalated	
between	the	DNA	base	pairs	the	phenazine	nitrogens	are	protected	from	water	and	
the	complexes	become	luminescent,	which	enable	studies	of	the	threading	process	
by	 fluorescence	 spectroscopy.	 By	 contrast,	 the	 mononuclear	 10,13‐diaryl‐
substituted	dppz	 complexes	 studied	 in	Paper	 III	 are	non‐luminescent	 in	aqueous	
solution	 as	 well	 as	 acetonitrile	 and	 when	 bound	 to	 DNA,	 and	 can	 thus	 not	 be	
studied	by	 fluorescence	 spectroscopy,	while	 the	 imdazophenantroline	 complexes	
used	as	cellular	probes	in	Paper	V	luminesce	brightly	regardless	of	solvent.	
3.4 Probing	DNA	Binding	by	Emission	Spectroscopy	
When	an	emissive	molecule	is	excited	to	a	higher	electronic	state,	it	will	remain	in	
the	 excited	 state	 for	 a	period	of	 time	before	 it	 relaxes	 to	 the	 ground	 state.	 Since	
emission	 of	 light	 is	 a	 random	process,	 the	 time	 spent	 in	 the	 excited	 state	 varies	
within	 a	 population	 of	 excited	molecules.	 Thus,	 the	 emission	 of	 a	 population	 of	
chromphores,	 all	 excited	 at	 t	 =	 0,	 is	 a	 first	 order	 decay	 process	 (Equation	 3.2)	
where	 the	 emission	 intensity	 It	 reflects	 the	 fraction	 of	 molecules	 that	 are	 still	
excited	at	time	t	after	excitation	and	the	emission	lifetime		describes	the	average	
time	spent	in	the	excited	state.	
	
ܫ௧ ൌ ܫ଴݁ݔ݌൫െݐ ߬ൗ ൯	 	 	 (Equation	3.2)	
	
The	emission	lifetime	depends	on	the	rates	of	both	the	emissive	and	non‐emissive	
relaxation	 processes	 according	 to	 Equation	 3.3	where	kr	 and	knr	 denote	 the	 rate	
constants	for	radiative	and	non‐radiative	relaxation	processes,	respectively.		
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߬ ൌ 	 ଵ௞ೝା௞೙ೝ		 	 	 	 (Equation	3.3)		
In	a	population	of	excited	molecules,	not	all	of	them	will	relax	by	emission	of	light	
but	some	will	return	to	the	ground	state	by	non‐radiative	processes.	The	fraction	
of	molecules	that	relaxes	via	emissive	processes	depends	on	the	relative	size	of	kr	
and	knr.	If	kr	is	larger	than	knr,	relaxation	is	more	likely	to	occur	by	emission	of	light,	
and	 vice	 versa.	 The	 efficiency	 of	 the	 emission,	 i.e.	 how	 many	 of	 the	 absorbed	
photons	 that	 will	 be	 emitted	 as	 light	 upon	 relaxation,	 is	 given	 by	 the	 emission	
quantum	yield	Φ:81	
	
Φ ൌ 	 ௞ೝ௞ೝା௞೙ೝ		 	 	 	 (Equation	3.4)		
While	 kr	 is	 an	 intrinsic	 property	 of	 the	 fluorophore	 knr	 is	 very	 sensitive	 to	 the	
environment,	and	as	a	consequence	both	the	emission	lifetimes	and	quantum	yield	
can	 be	 used	 to	 probe	 the	 environment	 of	 a	 chromophore.	 For	 dppz	 complexes,	
where	the	accessibility	of	the	dppz	ligand	to	hydrogen	bonding	water	is	the	major	
factor	 controlling	 the	 emission,	 these	 properties	 reflect	 the	 environment	 of	 the	
dppz	 ligand.	 A	 high	 quantum	 yield	 and	 long	 emission	 lifetimes	 are	 indicative	 of	
efficient	 protection	 of	 the	 dppz	 ligand	 from	 water,	 and	 by	 comparison	 of	 those	
parameters	 for	 different	 complexes	 in	 the	 presence	 of	 DNA	 conclusions	 can	 be	
made	about	their	relative	binding	constants	and	their	binding	modes.	In	particular,	
if	 there	 are	 differences	 in	 the	 emission	 lifetimes	 between	 two	 DNA	 bound	
enantiomers	 of	 the	 same	 complex,	 these	 differences	 must	 be	 due	 to	 different	
binding	 modes	 because	 enantiomers	 of	 the	 same	 molecule	 has	 the	 same	 kr.	
Further,	an	estimate	of	 the	relative	binding	constants	of	 two	enantiomers	can	be	
obtained	 by	 comparing	 their	 apparent	 intrinsic	 emission	 lifetimes.	 The	 intrinsic	
lifetime	τ0,	which	is	the	inverse	of	kr	and	thus	should	be	the	same	for	enantiomers	
of	 the	same	molecule,	 can	be	calculated	 from	the	observed	emission	 lifetime	and	
the	quantum	yield	according	to:	
	
߬଴ ൌ 	 ఛΦ	 	 	 	 (Equation	3.5)		
If	 the	 calculated	 intrinsic	 lifetime	 differs	 between	 the	 enantiomers,	 this	 is	 an	
indication	that	there	is	a	fraction	of	non‐emitting	species	in	the	samples,	which	in	
the	case	of	dppz	complexes	probably	are	complexes	that	are	not	intercalated	in	the	
DNA.	These	molecules	absorb	photons	at	the	excitation	wavelength	but	do	not	emit	
any,	 thus	 lowering	 the	 observed	 quantum	 yield	 resulting	 in	 erroneous	 intrinsic	
lifetimes.	The	relative	values	of	the	calculated	emission	lifetimes	reflect	the	relative	
fractions	 of	 non‐emitting	 species	 in	 the	 samples,	 and	 thus	 relative	 binding	
constants	can	be	estimated.	Finally,	the	existence	of	multiple	emission	lifetimes	in	
a	sample	containing	only	one	type	of	fluorophore	indicates	the	presence	of	several	
different	 species	 of	 the	 fluorophore.	 For	 dppz	 complexes,	 multiple	 emission	
lifetimes	 in	 presence	 of	 DNA	 are	 thought	 to	 arise	 from	 different	 intercalated	
species	with	different	accessibility	of	the	dppz	ligand	to	water.86		
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3.5 Determining	Binding	Geometry	by	Linear	Dichroism	
Because	absorption	is	most	efficient	when	the	electric	field	of	the	incident	light	is	
oscillating	 parallel	 to	 the	 transition	 dipole	 moment	 of	 the	 absorbing	 molecule	
(Equation	3.1),	the	absorption	of	linearly	polarized	light	by	a	molecule	will	largely	
depend	 on	 their	 relative	 orientations.	 This	 phenomenon	 is	 utilized	 in	 linear	
dichroism	(LD)	spectroscopy,	where	the	difference	in	absorption	of	light	polarized	
parallel	 and	 perpendicular	 to	 the	 reference	 axis	 of	 a	 macroscopically	 oriented	
sample	is	measured:88‐89		
	
ܮܦ ൌ ܣ∥ െ ܣ		 	 	 (Equation	3.6)	
	
There	are	several	available	methods	to	achieve	orientation	of	an	LD	sample,	such	
as	 the	 use	 of	 stretched	 polymers,	 electric	 or	magnetic	 field	 orientation	 and	 flow	
orientation.	Here,	Couette	cell	flow	orientation,	which	is	suitable	for	orientation	of	
long	 polymers	 such	 as	 DNA,	 has	 been	 used.90	 The	 Couette	 cell	 consists	 of	 two	
concentric	quartz	cylinders	with	a	narrow	spacing	in	between	where	the	sample	is	
applied.	Rotation	of	one	of	the	cylinders	creates	a	shear	flow	gradient	between	the	
cylinders	that	causes	the	long	DNA	molecules	to	align	in	the	flow	direction	(Figure	
3.3).	The	advantage	of	this	method	is	that	only	drug	molecules	bound	to	the	DNA	
give	rise	 to	LD	signals	since	 ligand	molecules	 free	 in	solution	are	 too	small	 to	be	
oriented.	
	
From	Equation	3.6	it	is	evident	that	an	LD	signal	larger	than	zero	indicates	that	the	
transition	dipole	moment	giving	rise	to	the	signal	is	oriented	more	parallel	to	the	
reference	axis	while	a	negative	signal	suggests	a	more	perpendicular	orientation.	
By	convention,	the	reference	axis	for	uniaxial	samples	is	defined	as	the	unique	axis	
of	the	sample.	Thus,	in	the	case	of	flow‐oriented	DNA	the	DNA	helix	axis	is	chosen	
as	 the	 reference	 axis,	 and	 consequently	 a	 negative	 LD	 signal	 means	 that	 the	
transition	dipole	moment	is	oriented	more	perpendicular	to	the	helix	axis.88‐89	
	
If	the	polarization	directions	of	the	transition	dipole	moments	within	the	molecule	
are	known,	a	more	quantitative	analysis	of	the	LD	spectra,	and	hence	the	binding	
geometry,	is	possible.	For	each	absorption	band,	the	angle	α	between	the	transition	
dipole	moment	 and	 the	 reference	axis	 can	be	 calculated	 from	 the	 reduced	 linear	
dichroism,	 LDr,	 which	 is	 the	 LD	 divided	 by	 the	 isotropic	 absorption,	 using	
Equation	3.7.	
	 	
ܮܦ௥ ൌ ஺∥ି஺஺೔ೞ೚ ൌ
ଷ
ଶ ܵሺ3ܿ݋ݏଶߙ െ 1ሻ		 	 (Equation	3.7)	
	
As	 previously	 described,	 the	 absorption	 spectra	 of	 ruthenium	 polypyridyl	
complexes	are	composed	of	several	different	electronic	transitions,	which	overlap	
each	other.	In	such	cases,	the	determination	of	the	binding	geometry	becomes	a	bit	
complicated	since	 the	LDr	of	each	 individual	 transition	dipole	moment	cannot	be	
directly	determined	from	the	experimental	LD	spectra.	However,	if	the	shape	of	the		
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Figure	3.3.	 Schematic	 picture	 of	 the	 Couette	 flow	 cell.	Rotation	 of	 the	 inner	 cylinder	
creates	a	shear	flow	in	which	long	molecules	are	aligned.	
	
absorption	spectra	of	each	individual	transition	dipole	moment	is	known,	as	well	
as	 their	 polarization	 directions	 within	 the	 molecule,	 α	 for	 all	 transition	 dipole	
moments	can	be	obtained	by	considering	all	 transitions	separately.	The	 isotropic	
absorption	spectra	can	be	seen	as	a	linear	combination	of	the	absorption	bands	of	
all	transition	dipole	moments.		Similarly,	the	LD	spectra	can	be	seen	as	a	weighted	
sum	of	the	same	absorption	bands,	where	the	weights	are	given	by	the	right	hand	
side	of	Equation	3.7.	Thus,	if	the	shapes	of	the	absorption	bands	are	known	for	all	
transition	 dipole	 moments,	 the	 overall	 absorption	 and	 LD	 spectra	 can	 be	
constructed	 by	 summarizing	 the	 different	 absorption	 bands	 multiplied	 by	
appropriate	weight	 factors.	 In	 this	 thesis,	 the	 reverse	has	been	done	 to	 calculate	
the	binding	geometries	of	mononuclear	ruthenium	complexes:	the	experimentally	
obtained	absorption	and	linear	dichroism	spectra	have	been	divided	into	separate	
absorption	bands,	 one	 for	 each	polarization	direction,	by	guessing	values	 for	 the	
weight	 factors.	 The	 residual	 norm	between	 the	 calculated	 and	 a	 set	 of	 reference	
absorption	 bands	 (see	 below)	 has	 then	 been	 minimized	 by	 varying	 the	 weight	
factors,	with	the	minimum	corresponding	to	the	most	probable	binding	geometry.	
	
This	 analysis	 is	 only	 possible	 when	 the	 polarization	 and	 spectral	 shape	 of	 the	
absorption	bands	of	the	DNA	binding	ligand	are	known,	and	unfortunately,	overlap	
of	the	absorption	bands	complicates	also	the	determination	of	their	polarizations	
and	 spectral	 shapes.	 However,	 for	 [Ru(phen)2dppz]2+	 the	 characteristics	 of	 the	
transition	 dipole	 moments	 have	 been	 fully	 assigned	 by	 Lincoln	 et	 al.	 using	 a	
combination	of	absorption,	linear	dichroism	and	emission	anisotropy	data.91‐93	The	
absorption	bands	obtained	for	[Ru(phen)2dppz]2+	have	been	used	in	this	thesis	as	
references	 for	 determining	 the	 binding	 geometry	 of	 two	 new	 mononuclear	
ruthenium	 complexes	 with	 substituents	 in	 the	 10‐	 and	 13‐position	 of	 the	 dppz	
ligand,	based	on	the	assumption	that		the	substituents	do	not	significantly	alter	the	
spectral	properties	of	the	complexes.		
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Figure	3.4.	The	orientation	of	the	B	polarized	transition	dipole	moments	depicted	on	the	
‐enantiomer	of	[Ru(phen)2dppz]2+.	The	A	polarized	transition	is	oriented	perpendicular	
to	 the	plane	of	 the	paper	along	 the	 long	axis	of	 the	dppz	 ligand	which	 is	pointing	out	
from	the	paper.		
	
The	 absorption	 spectrum	 of	 [Ru(phen)2dppz]2+	 can	 be	 divided	 into	 four	 major	
absorption	 bands,	 each	 being	 polarized	 along	 one	 of	 the	 four	 major	 transition	
dipole	moment	directions	A,	BE,	BA2,	and	Bsh	 (Figure	3.4).	The	A	and	Bsh	polarized	
transitions,	 which	 are	 mainly	 associated	 with	 MLCT	 and	 	 	 *	 transitions	
localized	on	 the	dppz	 ligand,	 are	polarized	 in	 the	plane	of	 the	dppz	 ligand.	 In	an	
intercalative	 binding	 geometry,	 these	 transitions	 will	 both	 be	 more	 or	 less	
perpendicular	to	the	DNA	helix,	and	are	therefore	treated	as	one	transition	dipole	
moment	with	α	=	90°	in	the	analysis.	The	BE	and	BA2	transitions	originates	mainly	
from	MLCT	and			*	transitions	localized	on	the	phenanthroline	ligands	and	are	
polarized	in	a	plane	perpendicular	to	the	long	axis	of	the	dppz	ligand.	The	LD	and	
LDr	of	these	transitions	will,	in	an	intercalative	binding	mode,	be	very	sensitive	to	
rotation	 around	 the	 dppz	 long	 axis.	 Thus,	 the	 binding	 mode	 of	 the	 new	
mononuclear	ruthenium	complexes	have	been	determined	by	comparison	of	their	
calculated	 BE	 and	 BA2	 polarized	 absorption	 bands	 with	 those	 previously	
determined	for	[Ru(phen)2dppz]2+	by	the	method	described	above.	
	
Calculation	 of	 the	 angles	 α	 from	 the	 LDr,	 and	 the	 method	 for	 determination	 of	
binding	 geometry	 described	 above,	 requires	 knowledge	 about	 the	 macroscopic	
orientation	 factor,	 which	 is	 denoted	 S	 in	 Equation	 3.7.	 The	 orientation	 factor	
reflects	how	well	 the	DNA	molecules	are	aligned	 in	 the	 sample,	 and	 ranges	 from	
zero	 to	 one,	where	 one	 corresponds	 to	 perfect	 orientation	 and	 zero	 to	 complete	
disorder.	Here,	the	orientation	factor	has	been	estimated	from	the	LDr	of	pure	DNA	
of	equal	concentration	as	in	the	ruthenium	containing	samples,	assuming	α	=	90°	
for	the	nucleobase	absorption	band	at	260	nm.	This	is	a	simple	method	and	gives	a	
reasonable	 estimate	 of	 the	 orientation	 factor	 in	 the	 ligand	 containing	 samples,	
provided	 that	binding	of	 the	 ligand	does	not	 significantly	alter	 the	orientation	of	
the	DNA.		
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3.6 Studying	DNA	Binding	by	Circular	Dichroism	
In	resemblance	to	the	LD	technique,	circular	dichroism	(CD)	spectroscopy	is	based	
on	differences	in	absorbance	of	polarized	light,	but	as	the	name	implies	circularly	
polarized	light	 is	used.	In	circularly	polarized	light	the	oscillation	direction	of	the	
electric	 field	 rotates	around	 the	propagation	direction,	and	 the	 tip	of	 the	electric	
field	vector	traces	out	a	helix	in	space.	The	helix	can	be	either	left	handed	or	right	
handed,	and	CD	is	defined	as	 the	difference	 in	absorbance	between	 left	and	right	
handed	circularly	polarized	light:	
	
ܥܦ ൌ ܣ௟ െ ܣ௥		 	 	 (Equation	3.8)		
Only	chiral	molecules	and	molecules	perturbed	by	a	chiral	environment	exhibit	CD.	
Both	DNA	and	 the	 investigated	ruthenium	complexes	are	chiral,	 and	 thus	exhibit	
CD	 signals	 on	 their	 own,	 but	 when	 studying	 DNA‐ligand	 interactions	 the	
phenomenon	 of	 induced	 CD	 is	much	more	 useful.	When	 small	 ligands,	 chiral	 or	
non‐chiral,	bind	to	the	chiral	DNA	polymer	in	an	orderly	manner,	their	transition	
dipole	 moments	 will	 interact	 with	 the	 nucleobase	 transition	 dipole	 moments	 in	
such	 a	 way	 that	 they	 will	 exhibit	 a	 new	 CD	 signal,	 the	 induced	 CD,	 that	 is	 only	
present	when	 the	 ligand	 interacts	with	DNA.89	A	change	 in	 the	CD	spectrum	of	a	
sample	of	DNA	and	ligand	reflects	a	change	in	the	interaction	between	the	DNA	and	
the	ligand,	and	thus	changes	in	binding	geometry	can	be	studied	by	CD.	However,	
in	contrast	to	LD,	where	there	is	a	simple	relation	between	the	LD	signal	and	the	
orientation	 of	 the	 chromophore,	 the	 origin	 of	 the	 induced	 CD	 signal	 is	 more	
complicated,	especially	when	there	are	several	different	transition	dipole	moments	
involved.	Consequently,	it	is	difficult	to	directly	relate	the	induced	CD	signal	of	the	
ruthenium	complexes	 to	 a	 specific	 binding	 geometry,	 and	 therefore	CD	has	been	
used	in	a	more	quantitative	way	in	this	thesis.	It	has	previously	been	shown	for	the	
well	 studied	 threading	 intercalator	 [‐bidppzRu2(phen)4]4+	 that	 threading	results	
in	a	large	positive	induced	CD	signal	in	the	visible	region,75,	94	and	similar	spectral	
changes	 observed	 for	 the	 ruthenium	 complexes	 investigated	 in	 this	 thesis	 have	
been	interpreted	as	rearrangement	from	an	initial	groove	bound	binding	mode	to	
threading	intercalation.	
3.7 Kinetic	Characterization	of	Threading	Intercalation	
As	 mentioned	 in	 the	 introduction,	 one	 of	 the	 main	 characteristics	 of	 threading	
intercalation	is	the	extremely	slow	association	and	dissociation	kinetics	compared	
with	 other	 DNA	 binding	modes.	 Therefore,	 in	 absence	 of	 structural	 information	
such	 as	 NMR	 or	 crystallography	 data,	 kinetic	 studies	 have	 become	 the	 main	
technique	 to	 confirm	 that	 a	 compound	 binds	 DNA	 by	 threading	 intercalation.33	
The	 threading	 intercalation	 kinetics	 has	 been	 thoroughly	 studied	 for	 the	 parent	
compound	[‐bidppz(phen)4Ru2]4+,	and	much	of	the	current	knowledge	regarding	
the	 kinetic	 behavior	 of	 this	 complex	 is	 relevant	 also	 for	 the	 complexes	 studied	
here	considering	their	similar	structure	and	DNA	binding	modes.		
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It	was	early	discovered	that	the	ruthenium	complex	rapidly	binds	to	the	groove	of	
the	DNA,	after	which	the	much	slower	rearrangement	to	the	threaded	state	takes	
place.73	Thus,	the	threading	event	can,	at	least	at	low	binding	ratios,	be	seen	as	a	
unimolecular	 reaction	 occurring	 from	 the	 groove	 bound	 state,	 where	 there	 is	 a	
pre‐equilibrium	between	complexes	in	the	groove	bound	state	and	free	in	solution	
(Figure	3.5).	The	observed	reaction	rate	for	the	threading	event	can	therefore	be	
described	by	Equation	3.9	where	 the	 first	 term	on	 the	 right	hand	side	describes	
the	 threading	event	 from	 the	groove	bound	 state.	The	 second	 term	accounts	 for	
dissociation	of	complexes	from	the	threaded	state,	which	also	has	to	be	included	in	
the	model	since	there	 is	an	equilibrium	also	between	the	threaded	state	and	the	
other	states.74‐75	
	
ௗሾ஼ሿ
ௗ௧ ൌ ݇ଶ
௞భ
௞షభ ሾܤሿ െ ݇ିଶሾܥሿ		 	 (Equation	3.9)		
Provided	 that	 the	 threading	 association	 rate	 constant	 is	 much	 larger	 than	 the	
corresponding	dissociation	rate	constant	and	that	the	equilibrium	between	groove	
bound	and	 free	 complex	 is	 shifted	 towards	 the	groove	bound	 form,	 it	 is	 evident	
from	Equation	3.9	 that	 the	kinetic	 trace	 for	mixing	complex	with	DNA	should	be	
mono‐exponential	 with	 a	 rate	 constant	 corresponding	 to	 the	 threading	
intercalation	rate	constant.	This	is	indeed	the	case	when	the	threading	reaction	is	
monitored	by	CD,	but	when	 studied	by	emission	 spectroscopy	 the	kinetic	 traces	
are	multi‐exponential.	Detailed	studies	of	 this	phenomenon	have	shown	that	 the	
fastest	exponential	of	the	emission	traces	corresponds	to	the	threading	event,	and	
the	 other	 exponentials	 have	 been	 assigned	 to	 redistribution	 of	 threaded	
complexes	along	the	DNA	polymer.75	When	the	dissociation	rate	constant	is	larger	
than	 or	 of	 the	 same	 magnitude	 as	 the	 association	 rate	 constant,	 studies	 of	 the	
association	 kinetics	 is	 complicated	 by	 the	 fact	 that	 also	 the	 dissociation	 rate	
contributes	to	the	observed	kinetic	trace,	and	the	association	rate	constant	cannot	
be	accurately	determined.	
	
A	 well	 established	 method	 to	 study	 dissociation	 kinetics	 of	 hydrophobic	 and	
cationic	molecules	 from	DNA	is	 to	 induce	dissociation	by	addition	of	a	detergent	
such	as	sodium	dodecyl	sulfate	(SDS)	to	equilibrated	samples	of	ligand	and	DNA.95	
The	detergent	will,	provided	that	the	concentration	is	high	enough,	form	micelles	
that	act	as	a	sequestering	agent	that	captures	ligands	that	are	free	in	solution,	thus	
shifting	the	equilibrium	towards	unbound	 ligand.	Since	there	 is	no	 ligand	free	 in	
solution	 no	 binding	 reaction	 occurs,	 and	 the	 dissociation	 rate	 constant	 can	 be	
determined	by	monitoring	how	the	amount	of	bound	complex	changes	with	time.	
However,	 SDS	 has	 been	 shown	 to	 catalyze	 the	 dissociation	 of	 ruthenium	
complexes	as	well	as	other	ligands	from	DNA7,	76,	96	and	therefore	the	dissociation	
rate	 constants	determined	by	 this	method,	 as	 the	ones	 reported	here,	 should	be	
interpreted	with	caution.		
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Figure	 3.5.	 Schematic	 picture	 of	 the	 threading	 event.	 The	 complex	 rapidly	 binds	
externally	on	the	DNA,	from	where	threading	occurs.	
	
The	 criterion	 that	 the	 kinetics	 of	 a	 threading	 intercalating	 compound	 should	 be	
significantly	slower	than	for	its	non‐threading	analogues	is	somewhat	ambiguous,	
and	 the	 rate	 constants	 for	 both	 threading	 and	 non‐threading	 interactions	 vary	
greatly	between	different	classes	of	compounds.7,	33,	44‐45,	49,	56,	73	Therefore,	it	is	not	
possible	 to	 determine	 a	 general	 cutoff	 value	 for	 the	 rate	 constant	 that	
distinguishes	 threading	 intercalation	 from	 other	 binding	modes,	 but	 instead	 the	
measured	 rate	 constants	 have	 to	 be	 compared	 with	 those	 of	 known	 threading	
intercalators	and	non‐threading	compounds	of	the	same	class.	The	rate	constants	
for	 SDS	 induced	 dissociation	 from	 ct‐DNA	 for	 the	 mononuclear	 non‐threading	
complex	 [Ru(phen)2dppz]2+	 and	 the	 known	 threading	 intercalator	 [‐bidppz‐
(phen)4Ru2]4+,	 which	 at	 room	 temperature	 are	 in	 the	 order	 of	 1‐10	 s‐1	 and	
10‐3‐10‐4	s‐1	 respectively,	 can	 be	 used	 as	 reference	 values	 for	 the	 numbers	
reported	in	this	thesis.73,	97	The	kinetics	has	mainly	been	studied	by	monitoring	the	
change	 in	emission	or	 the	 induced	CD	signal	 in	 the	visible	 region	with	 time,	but	
also	 absorbance	 spectroscopy	 has	 been	 used	 to	 study	 the	 mononuclear	
disubstituted	dppz	complexes	which	are	non‐luminescent.		
3.8 Binding	Thermodynamics	and	Isothermal	Titration	Calorimetry	
While	 there	 are	 a	 number	 of	 available	 methods	 to	 determine	 the	 equilibrium	
constant	K,	and	hence	the	 free	energy	change	G	of	a	binding	event,	 the	binding	
enthalpy	H	can	be	directly	assessed	only	by	calorimetric	methods.	In	isothermal	
titration	calorimetry	(ITC)	the	ligand	is	titrated	into	the	sample	cell	containing	the	
macromolecule	(or	vice	versa).	The	heat	evolved	or	absorbed	upon	each	addition	
of	 ligand	 is	 measured	 as	 the	 heat	 flow	 required	 to	 or	 from	 the	 sample	 cell	 to	
maintain	the	cell	at	the	same	temperature	as	a	reference	cell	of	equal	volume.	The	
enthalpy	 change	 for	 each	 injection	 is	 obtained	 as	 the	 integrated	heat	 flow,	 from	
which	the	binding	enthalpy	can	be	determined	provided	that	the	concentrations	of	
ligand	and	macromolecule	are	known.		
	
In	 the	 simplest	 system,	 where	 the	 binding	 sites	 on	 the	 macromolecule	 are	
independent	 and	 ligand	 binding	 is	 non‐cooperative,	 the	 ITC	 curve	 will	 have	 a	
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sigmoidal	shape.	For	the	first	few	injections,	virtually	all	injected	ligand	binds	the	
macromolecule	 since	 there	 are	 many	 free	 binding	 sites	 available,	 and	 the	
integrated	 heat	 reflects	 the	 binding	 enthalpy.	 As	 the	 binding	 sites	 gradually	
becomes	 saturated,	 only	 a	 fraction	 of	 the	 injected	 ligand	 will	 bind	 the	
macromolecule	 and	 the	 observed	 enthalpy	 change	 will	 decrease	 resulting	 in	 a	
curved	region	in	the	ITC	profile,	where	the	curvature	depends	on	K	and	the	total	
number	 of	 binding	 sites.	 Eventually,	 when	 all	 binding	 sites	 are	 occupied	 by	
ligands,	 further	 addition	 of	 ligand	 will	 not	 result	 in	 any	 binding.	 The	 enthalpy	
change	for	these	last	few	injections	would,	since	no	binding	occurs,	ideally	be	due	
only	to	dilution	of	ligand,	which	can	be	measured	and	corrected	for	by	a	separate	
experiment	where	ligand	solution	is	titrated	into	buffer.	However,	also	differences	
in	 the	 buffer	 composition,	 such	 as	 differences	 in	 ion	 concentration	 or	 pH,	 may	
result	 in	 an	 additional	 heat	 of	 mixing.	 To	 minimize	 these	 effects,	 the	 macro‐
molecule	 solution	 is	 dialyzed	 against	 a	 large	 volume	 of	 buffer,	 and	 the	 ligand	
solution	is	then	prepared	by	diluting	the	ligand	in	the	dialysate.98	
	
As	 mentioned	 above,	 the	 integrated	 heat	 of	 the	 first	 few	 injections	 reflects	 the	
binding	enthalpy,	but	since	the	amount	of	bound	ligand	for	each	injection	in	reality	
depends	 on	K	 also	 at	 low	 ligand	 concentrations	 iterative	 fitting	 of	 a	 theoretical	
binding	isotherm	to	the	data	has	to	be	employed	to	determine	H	accurately.	The	
integrated	 heat	 for	 each	 injection	 Qi	 is	 related	 to	 the	 binding	 enthalpy	 H	
according	 to	Equation	3.10,	where	 the	molar	 increase	of	bound	 ligand	with	each	
injection	is	given	by	[Li]bound×Vcell.	
	 	
ܳ௜ ൌ ∆ሾܮ௜ሿ௕௢௨௡ௗ ௖ܸ௘௟௟∆ܪ		 	 	 (Equation	3.10)		
In	the	regression	procedure,	[Li]bound	is	calculated	for	each	injection	based	on	the	
known	total	concentration	of	added	ligand	and	guessed	values	for	K	and	the	total	
concentration	 of	 binding	 sites.	 The	 best	 values	 for	 H,	 K	 and	 the	 number	 of	
binding	 sites	 on	 each	 macromolecule	 are	 obtained	 by	 minimizing	 the	 error	
between	 the	 calculated	 and	 experimental	 values	 for	Qi.98‐99	 Once	H	 and	K	 has	
been	 determined,	G	 and	S	 for	 the	 binding	 reaction	 can	 be	 obtained	 from	 the	
following	relations:	
	
∆ܩ ൌ െܴ݈ܶ݊ܭ		 	 	 (Equation	3.11)	
	
∆ܩ ൌ ∆ܪ െ ܶ∆ܵ		 	 	 (Equation	3.12)	
	
By	calorimetric	studies	at	several	different	temperatures,	the	heat	capacity	change	
for	the	reaction	Cp	can	be	obtained	from	the	slope	of	a	plot	of	H	versus	T.	Cp	is	
defined	 as	 the	 difference	 in	 heat	 capacity	 between	 products	 and	 reactants,	 and	
describes	 how	 H	 and	 S	 varies	 with	 temperature.	 As	 there	 is	 a	 correlation	
between	Cp	 and	changes	 in	 surface	area	accessible	 to	 solvent,	 the	magnitude	of	
Cp	 reflects	 the	 contribution	 of	 hydrophobic	 interactions	 to	 the	 binding	 free	
energy.99‐102	
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3.9 Binding	Isotherms	and	the	McGhee‐von	Hippel	Model	
When	 the	 binding	 sites	 on	 the	 macromolecules	 are	 independent	 and	 isolated,	
which	 is	often	 the	case	 for	proteins	and	short	oligonucleotides	with	one	defined	
binding	site,	 the	above	analysis	 is	 relatively	straight	 forward.	However,	 the	DNA	
used	 in	 the	 experiments	 presented	 here,	 poly[dAdT]2,	 are	 long	 polymers	 of	
binding	sites,	which	overlap	each	other	if	the	ligand	occupies	more	than	one	base	
pair	when	bound.	Furthermore,	if	the	bound	ligands	interact	with	each	other,	the	
interactions	 may	 be	 either	 cooperative	 or	 anti‐cooperative	 and	 give	 rise	 to	 an	
interaction	enthalpy	h	 in	addition	to	the	intrinsic	binding	enthalpy	H.	 In	1974	
McGhee	 and	 von	 Hippel	 presented	 a	 method	 for	 calculation	 of	 the	 fraction	 of	
bound	 ligands	 that	 accounts	 for	 both	 ligand‐ligand	 interactions	 and	 ligands	
covering	 more	 than	 one	 base	 pair.103	 If	 a	 ligand	 binds	 DNA	 with	 two	 different	
binding	 geometries	 the	 McGhee‐von	 Hippel	 theory	 for	 two	 distinct	 ligands	
competing	 for	 the	 same	 binding	 sites	 on	 the	 DNA	 can	 be	 used	 to	 calculate	 the	
binding	 isotherms.	 The	 mass	 balance	 equations	 for	 the	 two	 bound	 species	 are	
coupled	though,	because	there	is	no	difference	between	the	 ligands	when	free	in	
solution	and	both	bound	species	consequently	are	in	equilibrium	with	a	common	
pool	of	free	ligands.	However,	if	the	cooperativity	parameters	are	not	unity,	as	for	
the	ruthenium	complexes	investigated	in	Paper	IV,	the	original	McGhee‐von	Hippel	
equations	of	can	no	longer	be	used.	Instead,	a	matrix‐based	generalized	McGhee‐
von	Hippel	method	is	required,	which	is	briefly	summarized	below.104	
	
In	the	McGhee‐von	Hippel	theory	the	DNA	is	treated	as	a	one	dimensional	lattice	of	
binding	 sites	 (residues),	 and	 conditional	 probabilities	 are	 used	 to	 calculate	 the	
number	 of	 free	 binding	 sites	 and	 occurrence	 of	 ligand‐ligand	 interactions.	 The	
probability	of	finding	a	ligand	of	type	i	bound	to	a	randomly	chosen	binding	site	is	
given	 by	 the	 binding	 density	 i,	 which	 is	 defined	 as	 the	 ratio	 between	 the	
concentration	of	bound	 ligand	 i	 and	 the	 total	concentration	of	binding	sites.	The	
probability	 that	 a	 residue	 occupied	 by	 a	 ligand	 of	 type	 i	 is	 followed	 a	 residue	
occupied	by	a	 ligand	of	 type	 j	when	moving	 in	one	direction	along	 the	 lattice,	 is	
denoted	pij,	and	the	cooperativity	parameter	for	the	interaction	is	denoted	yij.	The	
conditional	probabilities	pij	 for	all	possible	combinations	of	a	ligand	binding	next	
to	another	ligand	or	a	free	base	pair	are	assembled	into	the	matrix	P.	Similarly,	the	
elements	of	the	matrix	Y	gives	the	cooperativity	parameters	for	the	corresponding	
interactions.	The	propability	of	finding	a	free	base	pair	(which	is	defined	as	type	1)	
on	the	DNA	lattice	is	given	by	θ1	=	1	‐	Σniθi	where	ni	 is	the	number	of	base	pairs	
made	 inaccessible	 by	 the	 bound	 ligand	 and	 the	 summation	 is	 over	 all	 types	 of	
bound	 ligands.	 The	 vector	 e	 =	 [1	 .	 .	 .	 1]	 and	 the	 transposition	 of	 the	 vector	
	=	[1	.	.	.	N]	containing	the	binding	densities	for	all	types	of	bound	species	i,	are	
right	 and	 left	 hand	 eigenvectors	 to	 P,	 respectively	 and	 are	 used	 to	 rearrange	
Equation	3.13	into	Equation	3.14	and	3.15	(see	below).		
	
To	 calculate	 the	 binding	 and	 interaction	 enthalpies	 and	 simulate	 ITC	 data,	 the	
amount	of	ligand	bound	and	ligand‐ligand	interactions	in	each	titration	step	has	to	
be	found.	Thus,	the	objective	of	the	McGhee‐von	Hippel	analysis	is,	given	binding	
25 
 
constants	Ki,	cooperativity	parameters	yij,	and	binding	site	sizes	ni,	to	find	a		that	
satisfy	 the	 mass	 balance	 equations,	 i.e.	 the	 total	 amount	 of	 ligand	 in	 the	
calculations	 Lcalc	 should	 equal	 the	 total	 amount	 of	 ligand	 added	 during	 the	
experiment	 Ladded,	 which	 in	 addition	 to	 the	 total	 concentration	 of	 binding	 sites	
[B]tot	is	known.	This	is	done	by	guessing	values	for	Ki,	yij,	ni,	and	,	which	are	then	
optimized	by	iteration	as	follows:	The	cooperativity	parameters	can	be	converted	
into	 conditional	 probabilities	 by	 multiplication	 with	 the	 matrices	 S	 and	 R	
(Equation	 3.13),	 which	 are	 diagonal	 matrices	 with	 positive	 elements	 such	 that	
pij	=	siyijrj.	 S	 and	 R	 are	 found	 by	 iteration	 using	 Equations	 3.13	 and	 3.14	 until	
rk+1	=	rk,	where	r	and	s	are	column	vectors	containing	the	diagonal	elements	of	R	
and	S,	respectively.	
	
۾ ൌ ܁܇܀	 	 	 	 (Equation	3.13)	
	
ܛ௞ ൌ 1./ሺ܇ܚ௞ሻ	 	 	 (Equation	3.14)		
ܚ௞ାଵ ൌ ી./ሺ܇୘܁௞ીሻ	 	 	 (Equation	3.15)		
The	 binding	 potential	 xi	 and	 the	 free	 ligand	 concentration	 [L]	 is	 calculated	 by	
inserting	 the	 elements	 of	S	 and	R	 into	Equation	3.16,	which	 in	 turn	 are	 used	 to	
calculate	Lcalc	according	to	Equation	3.17.	The	error	between	Lcalc	and	Ladded	is	then	
minimized	by	a	Newton‐Raphson	algorithm	where		is	varied.	
	
ݔ௜ ൌ ܭ௜ሾܮሿ ൌ ሾ௅೔஻ሿሾ஻ሿ ൌ
௣ሺ௅೔஻ሻ
௣ሺ஻ሻ ൌ
௣భ೔௣೔భ
௣భభ
೙೔శభ ൌ ௦೔௥೔௣భభ೙೔ 	 (Equation	3.16)		
ܮ௖௔௟௖ ൌ ሾܮሿ௙௥௘௘ ൅ ሾܮሿ௕௢௨௡ௗ ൌ ௫೔௄೔ ൅ ሾܤሿ௧௢௧Σߠ௜	 (Equation	3.17)		
The	concentrations	of	the	bound	ligands	Li	in	each	titration	step	is	obtained	from	
the	 optimized	 ,	 as	 are	 the	 concentrations	 of	 the	 different	 combinations	 of	
interactions	using	Equation	3.18.	Thus,	the	change	in	the	concentrations	for	each	
titration	step	can	be	obtained	and	H	and	h	calculated	from	a	least	square	fit	to	
the	 experimental	 data.	 The	 error	 between	 the	 fitted	 and	 experimental	 heat	 per	
injection	is	then	minimized	by	varying	Ki,	yij,	and	ni.		
	
ߠ௜௝ ൌ ߠ௜݌௜௝	 	 	 	 (Equation	3.18)	
3.10 Studying	Cell	Interactions	by	Confocal	Microscopy	
DNA	binding	studies	 in	 simple	and	well‐defined	systems	are	 important	 to	obtain	
detailed	mechanistic	knowledge	of	the	binding	event.	In	living	cells,	however,	the	
DNA	is	found	in	a	much	more	complex	environment	consisting	of	lipid	structures,	
proteins,	 RNA,	 ions	 and	 small	 organic	molecules,	which	may	 interfere	with	DNA	
binding.	 Therefore,	 it	 is	 of	 great	 importance	 to	 also	 study	 how	 the	 complexes	
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interacts	with	cells,	which	is	done	in	Paper	V.	This	section	gives	a	short	description	
of	the	cellular	structures	discussed	in	the	results	section	and	how	the	interactions	
between	ruthenium	complexes	and	such	structures	were	studied.		
	
All	cells	are	surrounded	by	a	phospholipid	bilayer,	the	plasma	membrane,	which	in	
addition	to	defining	the	boundaries	of	the	cell	also	serves	as	a	protective	barrier	by	
only	allowing	certain	specific	molecules	to	enter	or	leave	the	cell.	Inside	eukaryotic	
(e.g.	mammalian)	cells,	a	number	of	membrane	enclosed	compartments	are	found,	
such	as	mitochondria,	the	Golgi	apparatus	and	the	endoplasmatic	reticulum,	which	
are	commonly	referred	to	as	organelles.	All	organelles	have	specific	functions,	and	
the	most	 important	 organelle	 for	 this	work	 is	 the	 nucleus,	 in	which	 	 the	DNA	 is	
lodged	and	 replication	as	well	 as	 transcription	occurs.	The	nucleus	 also	 contains	
well‐defined	 but	 non‐membrane	 enclosed	 structures	 termed	 nucleoli,	 where	
ribosomal	 RNA	 is	 synthesized.	 The	 contents	 inside	 the	 plasma	 membrane,	
excluding	the	organelles,	is	termed	the	cytosol,	which	is	where	the	messenger	RNA	
produced	in	the	nucleus	is	translated	into	proteins.	Thus,	the	cytosol	contains	both	
RNA	 and	 proteins,	 as	 well	 as	 a	 wide	 variety	 of	 other	 biomolecules.	 To	 exert	 its	
action,	a	DNA	targeted	drug	has	to	pass	the	plasma	membrane	and	diffuse	through	
the	cytosol	without	being	 trapped	by	 interactions	with	other	molecules	 to	 finally	
enter	the	nucleus	where	it	can	bind	the	DNA.	Highly	charged	molecules,	as	the	ones	
studied	 here,	 are	 unlikely	 to	 pass	 the	 plasma	membrane	 by	 diffusion	 due	 to	 the	
hydrophobic	 interior	 of	 the	 lipid	 bilayer.	 There	 are	 other	 possible	 uptake	
mechanisms	 though,	 such	 as	 endocytosis,	 where	 extracellular	 fluid	 is	 captured	
inside	 lipid	vesicles,	 endosomes,	by	 the	 formation	of	 invaginations	 in	 the	plasma	
membrane	 that	 bud	 off	 into	 the	 cytosol.	 If	 the	 drug	 is	 internalized	 by	 this	
mechanism	 it	 may	 be	 eventually	 be	 released	 into	 the	 cytosol	 if	 the	 endosome	
ruptures,	provided	that	it	has	not	been	degraded	by	then.12		
	
An	 excellent	 technique	 to	 visualize	 the	 localization	 of	 emissive	molecules	 inside	
cells,	and	thus	their	preferences	for	various	biomolecules,	is	fluorescence	confocal	
laser	 scanning	microscopy	 (CLSM).	 In	 short,	 the	 chromophores	 are	 excited	 by	 a	
focused	laser	beam	and	only	emission	from	the	focal	point	is	detected.	By	moving	
the	 focal	 point	 across	 a	 plane	 in	 the	 sample,	 two‐dimensional	 images	with	 high	
spatial	 resolution	 can	 be	 created	 (see	 for	 example	 the	 textbook	 of	 Pawley	 for	
technical	 details105).	 The	 localization	 of	 the	 imidazophenanthroline	 complexes	 is	
readily	studied	by	CLSM	since	 they	are	highly	emissive	and	their	quantum	yields	
rather	insensitive	to	the	environment,	but	the	threading	intercalating	light‐switch	
complexes	 are	 only	 detectable	 when	 bound	 to	 hydrophobic	 structures.	 In	 this	
work,	the	interactions	with	both	live	and	fixed	cells,	where	the	plasma	membrane	
has	been	permeabilized	by	addition	of	cold	methanol	to	the	cells,	are	studied.	The	
advantage	 of	 fixation	 is	 that	 the	 preferences	 for	 various	 biomolecules	 can	 be	
investigated	 in	 the	 intracellular	 milieu,	 since	 the	 uptake	 is	 not	 limited	 by	 poor	
transport	 over	 the	 plasma	 membrane,	 whereas	 live	 cell	 studies	 reflects	 what	
would	actually	happen	to	the	complexes	inside	cells.	
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The	aim	of	this	work	is	to	investigate	the	relationship	between	ruthenium	complex	
structure	and	selective	DNA	binding.	The	study	is	primarily	focused	on	binuclear	
ruthenium	 complexes	with	 phenanthroline	 auxiliary	 ligands,	where	 the	 effect	 of	
bridging	 ligand	 structure	 and	 chirality	 around	 the	 ruthenium	 centers	 on	 AT‐
selective	DNA	threading	intercalation	is	investigated	(Paper	I‐II).	Also,	a	new	type	
of	mononuclear	threading	intercalating	complexes,	with	a	substitution	pattern	on	
the	 intercalating	 ligand	 that	 is	 different	 from	 all	 previously	 published	 threading	
complexes,	has	been	developed	(Paper	III).	Further,	 the	DNA	binding	of	the	non‐
threading	 mononuclear	 complexes	 [Ru(phen)2dppz]2+	 and	 [Ru(bpy)2dppz]2+,	
which	correspond	to	the	smallest	common	structural	part	of	all	known	threading	
intercalating	 ruthenium	 complexes,	 has	 been	 investigated	 with	 isothermal	
titration	calorimetry	to	better	understand	the	nature	of	the	interactions	between	
the	 complexes	 and	 DNA	 (Paper	 IV).	 Finally,	 cell	 studies	 on	 several	 binuclear	
complexes	 have	 been	 performed	 to	 investigate	 how	 the	 results	 from	 the	 DNA	
binding	 studies	 in	 simple	 systems,	 such	 as	 pure	 DNA,	 correlates	 with	 the	 DNA	
binding	properties	in	the	more	complex	milieu	inside	cells	(Paper	V).	This	chapter	
summarizes	 the	 main	 results	 of	 Paper	 I‐V	 and	 also	 presents	 some	 relevant	
unpublished	data.			
4.1 Bridging	Ligand	Structure		
Despite	 numerous	 DNA	 binding	 studies	 on	 binuclear	 polypyridyl	 ruthenium	
complexes	 of	 similar	 size	 and	 shape	 as	 the	 known	 threading	 intercalator	
[‐bidppz(phen)4Ru2]4+,	 there	 are	 few	 reports	 of	 threading	 intercalating	
complexes.	 106‐116	 In	 addition	 to	 the	 thoroughly	 studied	 bidppz	 complexes,	 with	
1,10‐phenanthroline,	2,2’‐bipyridine	or	[12]aneS4	as	auxiliary	ligands,73,	75	the	only	
binuclear	ruthenium	complexes	known	to	bind	DNA	by	threading	intercalation	are	
their	 rigid	 analogue	 [‐dtpf(phen)4Ru2]4+	 and	 the	 flexible	 bis‐intercalator	 [‐C4‐
(cpdppz)2(phen)4Ru2]4+.35‐36,	 117	 Common	 to	 these	 complexes	 is	 that	 they	 all	
contain	 dppz‐moieties,	 and	 therefore	 we	 wanted	 to	 investigate	 whether	 this	
structure	is	necessary	for	threading	intercalation	to	occur.	In	Paper	I	we	compare	
threading	ability	of	three	binuclear	complexes	with	systematically	varied	bridging	
ligands:	 the	 parent	 complex	 [‐bidppz(phen)4Ru2]4+	 (1)	with	 two	dppz‐moieties,	
and	[‐m‐bipb(phen)4Ru2]4+	(2)	and	[‐dppzip(phen)4Ru2]4+	(3),	with	no	and	one	
dppz‐moieties,	respectively	(Figure	4.1).	
		
4 RESULTS
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Figure	 4.1.	 Structures	 of	 the	 investigated	 binuclear	 complexes:	 [‐bidppz‐
(phen)4Ru2]4+	(1),	 [‐m‐bipb(phen)4Ru2]4+	 (2),	 [‐dppzip(phen)4Ru2]4+	 (3),	 and	 [‐
bidppze(phen)4Ru2]4+	(4).	
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Figure	4.2.	LD	spectra	of	ct‐DNA	(~	100	M)	in	presence	of	increasing	concentrations	of	
‐2	 ([Ru]/[bp]	 =	 0,	 1/18,	1/16,	 1/12,	 1/11,	 1/10)	 at	 150	mM	NaCl.	The	 decreasing	
amplitude	of	the	DNA‐signal	at	260	nm	indicates	compaction	of	the	DNA	as	the	complex	
concentration	increases.	
	
Complex	2		has	essentially	the	same	shape	as	1,	but	is	expected	to	be	more	flexible	
compared	with	the	other	two	complexes	since	the	bridging	ligand	has	two	instead	
of	one	single	bond	where	rotation	can	occur.	Since	threading	intercalation	of	1	has	
been	proposed	to	locally	distort	the	B‐conformation	of	the	DNA	to	a	more	A‐form	
like	 structure78	 increased	 flexibility	was	believed	 to	 improve	 threading	 ability.	 If	
the	complex	could	adapt	its	conformation	to	fit	the	DNA	better,	this	would	reduce	
the	 stress	 on	 the	DNA	and	 the	B‐conformation	 could	be	maintained.	 Contrary	 to	
what	we	expected,	2	does	not	appear	to	thread	DNA	at	all.	LD	experiments	show	
loss	 of	 the	 DNA	 orientation	 with	 increasing	 concentration	 of	 2,	 as	 seen	 by	 the	
decrease	of	 the	DNA‐signal	amplitude	 in	Figure	4.2,	 indicating	compaction	of	 the	
DNA.	 In	 Paper	 V,	 the	 DNA	 binding	 properties	 of	 an	 isomer	 of	 2	 with	 para‐
substitution	 on	 the	 bridging	 ligand	 benzene	 ring	was	 investigated.	 This	 complex	
also	compacts	ct‐DNA	and	exhibits	no	signs	of	threading	intercalation.	
	
Complex	3,	on	the	other	hand,	binds	AT‐	but	not	ct‐DNA	by	threading	intercalation.	
This	 is	 seen	 by	 the	 slow	 increase	 in	 luminescence	 intensity	 with	 time	 upon	
addition	of	AT‐DNA	 to	 the	complex	and	 the	absence	of	 such	 intensity	changes	 in	
presence	 of	 ct‐DNA	 (Figure	 4.3).	 The	 dissociation	 rate	 constants	 for	 both	
enantiomers	are	approximately	1‐2	orders	of	magnitude	larger	than	for	1,	but	still	
much	 smaller	 than	 for	 non‐threading	 compounds,	 confirming	 that	 the	 binding	
mode	 with	 AT‐DNA	 is	 indeed	 threading	 intercalation.	 The	 faster	 dissociation,	
combined	 with	 the	 fact	 that	 the	 threading	 process	 is	 slower,	 indicates	 that	 the	
threading	 intercalation	 binding	 constant	 is	 significantly	 smaller	 for	 3	 compared	
with	1.	Complex	3	appears	to	be	 just	at	 the	border	of	being	capable	of	 threading	
intercalation	 as	 judged	 from	 photophysical	 experiments	 (see	 section	 4.2).	While	
‐3	 readily	 threads	 AT‐DNA,	 only	 a	 small	 fraction	 of	 ‐3	 is	 threaded	 at
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Figure	4.3.	Association	kinetics	of	 complex	3	at	50	 °C	and	150mM	NaCl.	From	 top	 to	
bottom:	‐3	+	AT‐DNA,	‐3	+	AT‐DNA,	‐3	+	ct‐DNA	and	‐3	+	ct‐DNA.	The	slow	
increase	 in	 luminescence	 in	 presence	 of	 AT‐DNA	 indicates	 that	 the	 binding	mode	 is	
threading	intercalation.	
	
equilibrium.	This	was	 later	 confirmed	also	by	CD	and	LD	experiments	as	well	 as	
kinetic	studies	in	Paper	II.	The	reduced	binding	constant	for	3	is	proposed	to	be	an	
effect	 of	 the	 bridging	 ligand	 being	 slightly	 shorter	 than	 for	 1,	 causing	 the	
phenanthrolines	on	both	ruthenium	centers	to	be	in	close	contact	with	the	DNA	in	
the	threaded	state,	thus	increasing	the	stress	exerted	on	the	DNA	by	the	threaded	
complex.	This	would	be	expected	to	result	in	the	interaction	being	more	sensitive	
to	 the	 flexibility	 of	 the	 DNA,	 which	 can	 explain	 the	 greater	 AT‐selectivity	 of	 3	
compared	with	the	parent	complex	1.	
	
To	 further	 investigate	 this	 hypothesis,	 a	 binuclear	 complex	 with	 an	 elongated	
bridging	 ligand,	 [‐bidppze(phen)4Ru2]4+	 (4),	 was	 synthesized	 and	 examined	
(Figure	4.1).	Both	enantiomers	of	4	seem	to	initially	compact	the	ct‐DNA	as	seen	by	
the	absence	of	complex	signals	and	a	reduced	amplitude	of	 the	DNA‐signal	 in	LD	
spectra	recorded	immediately	after	mixing.	However,	pronounced	complex	signals	
with	 the	 same	 characteristics	 as	 the	 ones	 for	 threaded	 1	 emerge	 for	 the	 ‐
enantiomer	 after	 20	 h	 incubation	 at	 50	 °C,	 indicating	 that	 ‐4	 bind	 DNA	 by	
threading	 intercalation	 (Figure	 4.4).	 For	 the	‐enantiomer	 the	 complex	 signals	
were	barely	visible	even	after	prolonged	 incubation,	suggesting	that	 the	majority	
of	the	complexes	remain	externally	bound	also	at	equilibrium.	Comparison	of	the	
association	rates	for	ct‐	and	AT‐DNA	shows	that	the	AT‐selectivity	is	more	or	less	
lost	 when	 the	 bridging	 ligand	 length	 increases	 supporting	 the	 above	 hypothesis	
(Figure	4.4).	Whether	the	 threading	 intercalation	binding	constant	 is	 larger	 for	4	
than	1	remains	to	be	investigated.	
	
Although	 the	 bridging	 ligand	 length	 clearly	 affects	 the	 threading	 intercalation	
properties	of	binuclear	ruthenium	complexes,	conservation	of	the	bridging	ligand	
length	 alone	 is	 not	 sufficient	 to	 the	 maintain	 threading	 intercalation	 ability.	
Instead,	 the	 presence	 of	 a	 dppz‐moiety	 seems	 more	 important	 for	 this	 type	 of
31 
 
		
Figure	4.4.	Left:	LD	spectra	of	‐4	(black)	and	‐1	(grey)	bound	to	ct‐DNA	after	20	h	
incubation	at	50	°C.	Right:	Kinetic	traces	for	the	association	of	‐4	to	AT‐	(black)	and	
ct‐DNA	(grey)	at	50	C.	Both	experiments	were	performed	at	50	mM	NaCl.	
	
binding,	as	seen	by	 the	 fact	 that	3	 and	‐4	which	contain	dppz‐moieties	 thread	
DNA	 while	 the	 two	 isomers	 of	 2	 do	 not.	 This	 can	 be	 due	 to	 the	 fact	 that	 the	
imidazophenanthroline(ip)‐moiety	 has	 a	 smaller	 hydrophobic	 surface	 than	 the	
dppz‐moiety,	making	 intercalation	of	 the	bridging	 ligand	of	2	 less	 favorable.	 It	 is	
also	possible	that	the	2‐isomers	interact	much	more	favorably	with	the	DNA	when	
bound	in	the	groove	as	a	result	of	the	increased	flexibility	and	hydrogen	bonding	
capacity.	 Recently,	 an	 analogue	 to	 the	 para‐substituted	 2,	 with	 an	 elongated	
bridging	ligand,	has	been	synthesized	and	assayed	for	threading	intercalation	but	
neither	this	complex	threads	DNA,	consistent	with	the	above	results.118	
4.2 Enantioselectivity	and	Enantiomeric	Preferences	of	the	Grooves	
As	described	above,	threading	intercalation	of	3	is	more	efficient	for	the	‐	than	
the	‐enantiomer,	which	is	contrary	to	what	 is	observed	for	threading	of	1	 into	
AT‐DNA.75	 To	 investigate	 the	 origin	 of	 this	 reversed	 enantioselectivity,	 the	 DNA	
binding	of	the	“meso”	enantiomeric	pair	of	3	(denoted		and	,	where	the	first	
and	 second	 symbol	 refer	 to	 the	 chirality	 on	 the	 dppz‐	 and	 ip‐part,	 respectively)	
was	studied	in	Paper	II.	Since	3	is	asymmetrical,	it	is	possible	to	distinguish	which	
part	of	 the	bridging	 ligand	 that	 is	stacked	between	 the	DNA	base	pairs,	and	 thus	
how	the	chirality	on	 the	 intercalated	and	non‐intercalated	halves	affects	binding,	
respectively.	Based	on	the	observation	of	a	light‐switch	effect	upon	threading	and	
the	 fact	 that	 the	 dppz‐moiety	 seems	 important	 for	 threading	 to	 occur,	 it	 was	
concluded	 that	 the	dppz‐part	 of	 the	 bridging	 ligand	 is	 stacked	between	 the	 base	
pairs.		
 
From	 photophysical	 data	 for	 the	 four	 isomers	 of	 3	 in	 presence	 of	 AT‐DNA	
(Table	4.1)	 it	 is	 evident	 that	 	 has	 the	 largest	 threading	 intercalation	 binding	
constant,	 followed	 by	 ,	 ,	 and	 finally	 .	 Kinetic	 studies	 reveal	 the	 same
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Table	4.1.	Photophysical	data	for	the	four	isomers	of	3	bound	to	AT‐DNA.	
Samplea	 τ1	/	ns	(α1)	 τ2	/	ns	(α2)	 τavgb	/	ns	 Φc	 τrel	d	/	ns	 %	bounde	
	 51	(0.80)	 559	(0.20)	 153	 0.15	 1021	 17	
	 54	(0.43)	 270	(0.57)	 177	 1	 177	 100	
	 51	(0.77)	 559	(0.23)	 168	 0.11	 1550	 11	
	 54	(0.47)	 270	(0.53)	 168	 0.83	 202	 88	
a120	μM	nucleotides	and	3.75	μM	complex	in	150	mM	NaCl	at	25	°C.	bAverage	emission	
lifetime	 calculated	 as	 τavg	 =	 α1τ1	 +	 α2τ2.	 cRelative	 quantum	 yields	 calculated	 by	
normalization	 of	 the	 integrated	 emission	 spectra	against	 the	 integrated	 spectrum	 for	
ΔΛ.	 dRelative	 intrinsic	 lifetimes	 calculated	 from	 τrel	 =	 τavg/Φ.	 ePercentage	 of	 bound	
complex	calculated	as	the	ratio	between	τrel	for	ΔΛ	and	τrel	for	the	complex		based	on	the	
assumptions	 that	 all	 ΔΛ	 is	 bound	 and	 that	 the	 intrinsic	 lifetime	 is	 the	 same	 for	 all	
isomers.	
	
pattern,	 with	 	 displaying	 the	 largest	 and		 the	 smallest	 ratio	 between	 the	
association	and	dissociation	rate	constants.	The	differences	in	association	rates	are	
modest,	 and	 the	 different	 binding	 constants	 appear	 to	 mainly	 be	 caused	 by	
variations	in	the	dissociation	rate	(Figure	4.5).	Moreover,	the	shape	of	the	LD	and	
CD	spectra	in	presence	of	AT‐DNA	changes	dramatically	with	time	for		and	,	
while	 the	 spectra	 for		 and		 remain	 essentially	 the	 same	 (Figure	 4.6).	 This	
reflects	 a	 rearrangement	 from	 an	 initial	 groove	 bound	 state	 to	 an	 intercalated	
geometry	 for	 the	main	 part	 of	 the	‐	 and	‐complexes,	 but	 suggests	 that	 the	
spectra	 for	 	 and	 	 are	 dominated	 by	 the	 groove	 bound	 form	 also	 at	
equilibrium.	All	together,	these	results	show	that		is	the	optimal	configuration	on	
the	 ruthenium	 center	 of	 the	 intercalating	 dppz‐part	 while	 ‐geometry	 is	 more	
favorable	on	the	non‐intercalating	ip‐part.	
	
The	LD	and	LDr	spectra	immediately	after	mixing	with	AT‐DNA	are	very	similar	for	
all	 four	 isomers,	 indicating	similar	 initial	binding	modes.	Also,	 the	LDr	 spectra	 in	
presence	of	ct‐DNA,	where	threading	does	not	occur,	are	nearly	identical	to	those	
immediately	after	mixing	with	AT‐DNA	(Figure	4.7).	This	indicates	that	the	initial	
binding	 is	 similar	 for	 the	 two	 types	 of	DNA	 and	 that	 the	 difference	 in	 threading	
ability	 lies	 in	 the	threaded	state	rather	than	in	the	 initial	groove	bound	state.		
appears	 to	have	 the	best	 structure	 to	 fit	 the	 threading	 intercalation	binding	 site,	
and	the	larger	flexibility	of	AT‐DNA	allows	better	accommodation	of	the	threaded	
complex	 than	 the	 more	 rigid	 ct‐DNA.	 Kinetic	 studies	 further	 support	 these	
conclusions	 since	 there	 are	 larger	 differences	 between	 the	 isomers	 in	 the	 SDS	
induced	dissociation	rates	than	in	the	association	rates.		
	
Comparison	 of	 the	 threading	 properties	 of	 	 and	 ,	 which	 both	 have	 one	
ruthenium	 center	 with	 “correct”	 chirality,	 shows	 that	 the	 geometry	 around	 the	
ruthenium	on	the	ip‐part	has	a	stronger	influence	on	the	threading	ability	than	the	
geometry	of	the	dppz‐ruthenium	center.	This	is	somewhat	surprising	considering	
the	 fact	 that	 the	dppz‐moiety	 is	assumed	to	 intercalate	the	DNA,	but	provides	an	
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Figure	4.5.	Left:	association	kinetics	of	‐3	(dark	blue)	and	‐3	(light	blue)	to	AT‐
DNA	studied	by	CD	spectroscopy	at	50C.	Both	complexes	display	first	order	kinetics	with	
similar	rate	constants.	Right:	dissociation	kinetics	of	‐3	(dark	blue),	‐3	(light	blue),	
‐3	(grey)	and	‐3	(black)	from	AT‐DNA	studied	by	fluorescence	spectroscopy	at	50	
C.	Dissociation	was	 induced	by	addition	of	a	stock	solution	of	3	%	SDS	to	equilibrated	
samples	of	complex	(3.5	µM)and	DNA	(120	µM)	 to	a	 final	concentration	of	0.6	%	SDS.	
The	kinetic	traces	have	been	corrected	for	dilution	and	normalized	against	the	emission	
intensity	 before	 addition	 of	 SDS.	 The	 kinetic	 traces	 are	 bi‐exponential	 and	 the	 four	
isomers	exhibit	significant	differences	in	dissociation	rate	constants.	
	
explanation	 for	 the	 reversed	 enantioselectivity	 with	 respect	 to	 1	 and	 4.	 For	
complexes	with	short	bridging	ligands,	also	the	phenanthrolines	of	the	ruthenium	
center	on	the	non‐intercalating	half	are	supposedly	in	close	contact	with	the	DNA,	
and	 are,	 as	 in	 the	 case	 of	 3,	 dominating	 the	 stereoselectivity.	 However,	 as	 the	
bridging	 ligand	 becomes	 longer,	 as	when	 going	 from	 complex	3	 to	1,	 the	 stress	
exerted	on	the	DNA	by	the	phenanthrolines	of	the	non‐intercalating	half	will	not	be	
as	 large	 and	 the	 importance	 of	 these	 interactions	 will	 decrease.	 Instead,	 the	
geometry	around	the	ruthenium	of	the	intercalating	part	will	be	dominating.	Since	
the	intercalating	parts	of	1	and	4	are	more	or	less	identical	to	that	of	3,	it	is	likely	
that	‐geometry	is	the	optimal	configuration	on	the	ruthenium	on	the	intercalating	
half	also	for	these	complexes,	resulting	in	the	reversed	enantioselectivity.	The	fact	
that	 the	‐enantiomer	of	4	 does	not	 seem	to	 thread	DNA	at	all	while	 the	same	
enantiomer	 of	1	 does,	 suggest	 that	 the	 non‐intercalating	 part	 of	1	 also	 interacts	
with	 the	 DNA	 in	 the	 threaded	 state,	 enabling	 threading	 intercalation	 of	 ‐1	
despite	the	fact	that		is	the	optimal	configuration	on	the	intercalating	part.	For	4,	
the	phenanthrolines	of	the	non‐intercalating	part	do	not	seem	to	be	able	to	make	
favorable	interactions	with	the	DNA,	at	least	not	in	the	‐configuration,	and	hence	
do	 not	 compensate	 for	 the	 less	 favorable	 interactions	 of	 the	‐geometry	 on	 the	
intercalating	half.	The	fact	that	the	long	emission	lifetime	of	3	is	controlled	by	the	
chirality	on	the	non‐intercalating	half	shows	that	the	phenantrolines	on	this	part	of	
the	complex	are	in	close	contact	with	the	DNA	in	the	threaded	state	and	has	great	
influence	on	the	binding	geometry,	which	supports	the	above	explanation.	
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Figure	4.6.	LDr	spectra	(top)	and	induced	CD	(bottom)	of	‐3	(dark	blue),	‐3	(light	
blue),	‐3	 (grey)	and	‐3	 (black)	 in	presence	of	AT‐DNA	 immediately	after	mixing	
(left)	and	at	equilibrium	(right).	‐3	and	‐3	display	dramatic	spectral	changes	with	
time	indicative	of	threading	intercalation,	whereas	only	minor	changes	are	observed	for	
‐3	and	‐3.	The	LDr	spectra	of	‐3	and	‐3	at	equilibrium	have	been	multiplied	
by	 a	 factor	 2	 for	 ease	 of	 comparison	 since	 these	 samples	 have	 lower	 orientation	 as	
judged	from	the	DNA‐signal.	The	experiments	were	performed	at	150	mM	NaCl	with	3.5	
µM	complex	and	120	µM	DNA.	
	
		
Figure	4.7.	LDr	 spectra	of	‐3	 (dark	blue),	‐3	 (light	blue),	‐3	 (grey)	and	‐3	
(black)	 in	presence	of	AT‐DNA	(left)	and	ct‐DNA	(right)	 immediately	after	mixing.	The	
similar	 spectral	 shapes	 indicate	 similar	 binding	modes	 for	 all	 four	 isomers	with	 both	
types	of	DNA.		
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Figure	4.8.	Structures	of	the	two	new	ruthenium	complexes	[Ru(phen)210,13‐diphenyl‐
dppz]2+	(P)	and	[Ru(phen)210,13‐di(2’‐thienyl)dppz]2+	(T).	
4.3 A	New	Substitution	Pattern	for	Threading	Intercalating	dppz	Complexes	
Aside	from	the	rigid	complex	[‐dtpf(phen)4Ru2]4+	and	the	bis‐intercalator	[‐C4‐
(cpdppz)2(phen)4Ru2]4+,	 all	 ruthenium	 complexes,	 both	 mono‐	 and	 binuclear,	
reported	 to	 bind	DNA	 by	 threading	 intercalation	 contains	 a	 dppz‐moiety	with	 a	
positively	charged	bulky	substituent	in	the	11‐position.73,	75,	119‐120	In	Paper	III,	we	
have	explored	a	new	substitution	pattern	for	threading	intercalating	mononuclear	
ruthenium	 complexes,	 where	 phenyl	 (P)	 or	 thienyl	 (T)	 substituents	 have	 been	
attached	to	the	dppz	ligand	in	10‐	and	13‐position	(Figure	4.8).	This	substitution	
pattern	 provides	 a	 new	 strategy	 for	 development	 of	 mononuclear	 threading	
intercalating	complexes,	but	the	binding	is	very	sensitive	to	the	nature	of	the	aryl	
substituents.	
	
Figure	4.9	shows	a	comparison	of	the	LDr	spectra	of	the	DNA‐bound	enantiomers	
of	P	and	T	with	the	corresponding	spectra	of	[Ru(phen)2dppz]2+,	which	is	known	
to	bind	DNA	by	intercalation	of	the	dppz	ligand.	The	similarities	of	the	LDr	spectra	
suggest	that	also	P	and	T	intercalate	DNA	by	insertion	of	the	aryl‐substituted	dppz	
ligand	between	the	base	pairs.	Calculations	of	the	roll	angles	for	P	and	T	from	LDr	
data,	i.e.	how	the	short	axis	of	the	dppz	ligand	is	oriented	relative	to	the	DNA	helix	
axis,	resulted	in	values	that	are	consistent	with	intercalation	of	the	dppz	ligand	for	
both	complexes	(Table	4.2).	
	
Despite these indications of similar binding modes for P and T, kinetic studies show 
otherwise. First, comparison of the LD spectra immediately after mixing of the 
complexes with DNA and at equilibrium reveal a slow change in binding mode with 
time for T while equilibrium is reached virtually instantly for P. Moreover, the 
dissociation rate differs significantly between the two complexes with T exhibiting very 
slow dissociation characteristic for threading intercalation. For P, on the other hand, it is 
difficult to judge whether the binding mode is classical or threading intercalation based 
on the dissociation rate constants (Table	 4.3), which are just in between those for 
known classical and threading intercalating reference compounds. However, due to the 
larger hydrophobic surface of the phenyl-substituted dppz ligand the binding constant is 
expected to be larger for P than for [Ru(phen)2dppz]2+ which may account for the
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Table	 4.2.	Roll	 angles	 for	 the	 ruthenium	 complexes	 bound	 to	 ct‐DNA.	 A	 positive	 roll	
angle	is	defined	as	the	clockwise	rotation	around	the	dppz	long	axis	when	looking	along	
the	dppz	ligand	from	the	ruthenium.	A	roll	angle	of	0	corresponds	to	the	dppz	short	axis	
being	oriented	perpendicular	to	the	DNA	helix	axis.		
Complex	 	 	
T	 +4°	 +14°	
P	 +9°	 ‐2°	
[Ru(phen)2dppz]2+	 +7°	 +13°	
	
 
Table	 4.3.	 Rate	 constants	 for	 SDS	 (0.6	 %)	 induced	 dissociation	 of	 the	 ruthenium	
complexes	from	ct‐DNA	at	25	°C	and	10	mM	NaCl.	
Complex	 k1	(10‐2	s‐1)	 α1	 k2	(10‐2	s‐1)	 α2	
Δ‐T		 10	 (0.33)	 2.5	 (0.67)	
Λ‐T	 2.2	 (0.38)	 0.42	 (0.62)	
Δ‐P		 90	 (0.59)	 12	 (0.41)	
Λ‐P		 63	 (0.56)	 14	 (0.44)	
Δ‐[Ru(phen)2dppz]2+		 140	 	 	 	
Λ‐[Ru(phen)2dppz]2+		 890	 	 	 	
	
	
		
Figure	4.9.	LDr	 spectra	of	 the	‐	 (left)	and	‐enantiomers	 (right)	of	T	 (dark	blue),	P	
(light	 blue)	 and	 [Ru(phen)2dppz]2+	 (black)	 in	 presence	 of	 ct‐DNA	 at	 equilibrium.	 The	
similar	spectral	shapes	in	the	UV‐region	indicate	similar	binding	geometries	for	all	three	
complexes.	 The	 differences	 in	 the	 visible	 region	 are	mainly	 due	 to	 differences	 in	 the	
isotropic	absorption.	Concentrations	of	complex,	DNA	and	NaCl	were	10,	120	and	10	µM,	
respectively.	
	
reduced	dissociation	rate	of	P.	Therefore,	the	binding	mode	of	P	is	proposed	to	be	
classical	 intercalation	 by	 insertion	 of	 part	 of	 the	 dppz	 ligand	 and	 one	 phenyl‐
substituent	 between	 the	 base	 pairs.	 In	 the	 threaded	 state	 envisioned	 for	T,	 the	
dppz	ligand	is	thought	to	be	intercalated	between	the	base	pairs	with	both	thienyl	
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substituents	 in	 the	 opposite	 groove	 relative	 to	 the	 ruthenium	 center.	 These	 two	
binding	modes	would	give	similar	LDr,	since	the	LDr	is	only	sensitive	to	the	angle	
between	the	transition	dipole	moments	and	the	orientation	axis,	but	explains	the	
difference	in	association	rates.	Passage	of	the	thienyl	substituents	through	the	base	
pair	stack	is	likely	to	represent	a	significant	energy	barrier	to	reach	the	threaded	
state,	and	would	account	for	the	slow	association	and	dissociation	observed	for	T.	
 
Considering the structural similarities of P and T, it is quite surprising that they have 
different binding modes. The distance between the outermost parts of the aryl-
substituents is slightly larger for P than T (13.6 versus 12.6 Å as determined from PM3-
optimized structures), and it is possible that P is too large while T is just small enough 
to pass through the base pair stack. This may explain why P does not thread DNA, but  
not why T does. A difference in stacking interactions between the aryl substituents and 
the DNA bases may explain the different binding modes. If the threading process is 
assumed to begin by insertion of one aryl-substituent between the base pairs, there must 
be a driving force for continued insertion of the ligand so that the dppz-part eventually 
becomes stacked between the base pairs with the aryl substituents in the groove. It is 
possible that the phenyl ring of P stacks very well with the bases so that there is no 
driving force for further insertion of the dppz ligand once the phenyl ring is intercalated, 
while the corresponding interactions are less favorable for the slightly thicker thienyl 
ring. 
 
Previously it has been shown that the dissociation rate of threaded complexes is highly 
dependent on the charge of the bulky substituent that is passed through the base pair 
stack.119 Therefore, it is interesting to note that the dissociation rate constants for -T 
are in the same range	 as	 those	 for	 mononuclear	 complexes	 with	 +1	 charged	
ammonium‐substituted	dppz	ligands.	Hence,	this	work	shows	that	the	dissociation	
rate	is	also	largely	affected	by	the	structure	and	position	of	the	bulky	substituents	
and	 that	 reduced	 charge	 on	 the	 bulky	 substituent	 can	 be	 compensated	 for	 by	
structural	changes	to	retain	the	slow	dissociation.  
4.4 Thermodynamics	and	Cooperativity	for	Intercalating	dppz	Complexes	
To	 date,	 all	 ruthenium	 complexes	 demonstrated	 to	 bind	 DNA	 by	 threading	
intercalation	contain	at	least	one	dppz‐moiety.	Therefore,	it	is	of	great	importance	
for	 this	work	 to	understand	the	 interactions	between	the	Ru‐dppz	structure	and	
DNA.	Binding	of	[Ru(phen)2dppz]2+	and	its	analogue	[Ru(bpy)2dppz]2+	to	DNA	was	
proposed	to	occur	by	 intercalation	of	the	dppz	 ligand	already	in	the	first	reports	
on	 their	 DNA	 interactions,	 but	 time‐resolved	 emission	 studies	 revealed	 two	
emission	lifetimes	indicating	two	different	modes	of	interaction.63‐64	The	origin	of	
the	 two	 lifetimes	 has	 been	 subject	 to	 much	 research,	 but	 despite	 numerous	
publications	 on	 this	matter	 consensus	 regarding	 the	 two	 lifetimes	 and	 the	 DNA	
binding	 mode	 has	 not	 been	 reached.	 Photophysical	 studies	 on	 enantiopure	
complexes	with	homogeneous	polynucleotides	 ruled	out	 sequence	heterogeneity	
to	be	the	cause	of	the	two	lifetimes	and	our	lab	proposed	them	to	originate	from	
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Figure	4.10.	 ITC	data	 for	titration	of	the	‐	(left)	and	‐enantiomers	(right)	of	PHEN	
(top)	and	BPY	(bottom)	into	AT‐DNA	(black)	at	15(■),	20	(),	25	(●)	and	30C	().	The	
solid	 lines	 are	 the	 simulated	 curves	 obtained	when	 fitting	 the	 data	with	 the	 binding	
model	described	below.	
	
isolated	 and	 contiguously	 bound	 complexes	 in	 the	 minor	 groove.64,	 92,	 121	 The	
Barton	group,	on	the	other	hand,	favored	intercalation	from	the	major	groove	with	
the	 two	 lifetimes	 being	 assigned	 to	 different	 intercalation	 geometries:	 one	with	
the	dppz	ligand	long	axis	centered	in	the	intercalation	pocket	and	one	with	a	more	
canted	 geometry.85,	 122‐125	 In	 Paper	 IV	 we	 have	 investigated	 the	 binding	 of	
enantiopure	[Ru(phen)2dppz]2+	(here	denoted	PHEN)	and	[Ru(bpy)2dppz]2+	(BPY)	
to	AT‐DNA	by	isothermal	titration	calorimetry	(ITC)	and	tried	to	correlate	the	ITC	
data	to	photophysical	data	to	shed	further	light	on	the	interactions	between	these	
complexes	and	DNA.	
	
Figure	4.10	shows	ITC	data	for	titration	of	the	four	complexes	into	AT‐DNA	at	15,	
20,	25	and	30	C.	The	shape	of	the	ITC	profiles	deviates	strongly	from	standard	ITC	
curves	 indicating	 that	 strong	 cooperativity	 effects	 are	 present.	 As	 the	 complex	
concentrations	 increase,	 binding	 of	 all	 four	 complexes	 gradually	 becomes	more	
exothermic	 until	 a	 [Ru]/[bp]	 ratio	 of	 approximately	 0.3‐0.4,	 but	 while	 the	 two	
‐complexes	 display	 similar	 ITC	 profiles,	 the	 differences	 to	 and	 between	 the	
‐enantiomers	are	striking.	The	signals	for	‐BPY	are	significantly	smaller	than	for	
the	 other	 three	 complexes,	 and	 ‐PHEN	 displays	 a	 plateau	 of	 constant	 heat	
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Figure	4.11.	Pre‐exponential	 factors	 for	the	 long	emission	 lifetimes	of	‐PHEN	(■),	‐
PHEN	(),	‐BPY	(●)	and	‐BPY	()	at	different	binding	ratios.	The	solid	lines	show	the	
simulated	 fractions	 of	 species	 A	 and	 B	 obtained	 by	 fitting	 the	 data	with	 the	 binding	
model	described	below.	The	data	is	nearly	identical	for	the	two	‐enantiomers.	
	
evolved	 for	 the	 first	 few	 injections	with	 a	more	 sharp	 decrease	 of	 the	 enthalpy	
compared	 with	 the	 other	 complexes.	 The	 shapes	 of	 the	 ITC	 profiles	 remain	
constant	with	varying	temperature,	but	the	reactions	become	more	exothermic	as	
the	temperature	increases.	
	
To	 correlate	 the	 ITC	 data	with	 previous	 photophysical	 studies,	 emission	 lifetime	
measurements	were	 performed	 at	 three	 binding	 ratios:	 [L]/[bp]	 =	 0.1,	 0.33	 and	
0.67	 corresponding	 to	 the	 low,	middle	 and	 high	 saturation	 regimes	 respectively.	
The	 pre‐exponential	 factor	 for	 the	 long	 emission	 lifetime,	 αlong	 increases	 with	
binding	ratio	for	all	complexes,	but	again	there	are	significant	differences	between	
the	 ‐enantiomers	 while	 the	 two	 ‐enantiomers	 display	 similar	 trends.	 αlong	 is	
substantially	 smaller	 for	 ‐BPY	 at	 all	 binding	 ratios	 compared	 with	 the	
‐enantiomers,	whereas	‐PHEN	displays	significantly	larger		values	(Figure	4.11).		
	
The	simplest	model	that	can	satisfactorily	fit	both	ITC	and	emission	lifetime	data	
includes	 two	bound	species	with	different	binding	geometries	 to	account	 for	 the	
two	emission	lifetimes,	one	of	which	is	polar	to	allow	both	cooperative	and	anti‐
cooperative	 interactions	 between	 the	 two	 (Figure	 4.12).	 The	 polar	 species	 is	
denoted	 A	 or	 B	 depending	 on	 the	 polarity,	 and	 the	 symmetrical	 species	 is	
denoted	C.	For	symmetry	reasons,	we	assign	species	C	and	A/B	to	a	centered	and	a	
canted	 intercalation	 geometry	 respectively,	 as	 proposed	 by	 Barton	 and	 co‐
workers,85	 but	 contrary	 to	 the	 original	 proposal	we	 attribute	 the	 long	 emission	
lifetime	to	the	canted	geometry.	This	is	based	on	the	fact	that	the	emission	lifetime	
of	dppz	complexes	depends	on	whether	only	one	or	both	phenazine	nitrogens	are	
accessible	 for	water.87	 If	 intercalation	occurs	 from	 the	minor	groove,	 this	would	
presumably	result	 in	one	nitrogen	being	fully	and	the	other	one	partly	protected	
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Figure	4.12.	Schematic	picture	illustrating	the	binding	model	with	polar	species	A	and	B	
and	the	non‐polar	species	C.	
	
from	water	in	the	in	the	canted	geometry,	which	would	result	in	quenching	being	
less	probable	than	for	the	centered	geometry	where	both	nitrogens	are	thought	to	
be	partly	accessible	to	water.	
	
As	 a	 consequence	 of	 αlong	 approaching	 zero	 at	 low	 binding	 ratios	 (unpublished	
data	at	10	mM	NaCl,	Lincoln	and	Tuite)	complexes	only	exist	as	A/B	when	they	are	
bound	 in	 close	 contact	 with	 another	 complex,	 implying	 that	 isolated	 complexes	
only	exist	in	geometry	C.	Further,	many	of	the	theoretically	possible	combinations	
of	complex‐complex	 interactions	have	been	excluded	 from	the	model	 for	sterical	
reasons	as	complexes	canted	towards	each	other	would	clash.	Only	the	complex‐
complexes	interactions	AB,	AC/CB	and	CC	are	allowed,	which	means	that	A/B	are	
present	only	at	the	ends	of	contiguous	sequences	and	only	the	centered	C	can	be	
accommodated	in	the	interior	of	such.	In	addition	to	the	intrinsic	binding	enthalpy,	
which	 is	 assumed	 to	 be	 the	 same	 regardless	 if	 the	 complexes	 are	 isolated	 or	
contiguously	 bound,	 complex‐complex	 interactions	 for	 the	 combinations	 AC/CB	
and	 CC	 are	 thought	 to	 give	 rise	 to	 an	 additional	 interaction	 enthalpy.	 The	
parameter	values	that	gave	the	best	fit	to	both	ITC	data	and	the	αlong‐values	(solid	
lines	 in	 Figure	 4.10	 and	 4.11)	 are	 presented	 in	 Table	 4.4	 along	 with	 thermo‐
dynamic	data	for	the	intrinsic	binding	obtained	at	20	°C	in	Table	4.5.	
	
Although	the	numbers	presented	in	Table	4.4	should	be	interpreted	with	caution	
since	the	parameters	in	the	model	are	not	all	independent	and	better	fits	may	be	
obtained	by	more	 complicated	models,	 several	qualitative	 conclusions	 regarding	
the	DNA	binding	of	the	studied	complexes	can	be	made.	Overall,	‐BPY	appears	to	
be	 most	 anti‐cooperative	 since	 all	 complex‐complex	 interactions	 are	 anti‐
cooperative,	in	contrast	to	the	binding	of	the	other	complexes	which	appear	to	be	
moderately	cooperative.	The	CC	interaction	is	anti‐cooperative	for	all	complexes,	
suggesting	that	they	are	reluctant	to	form	longer	contiguous	sequences	than	three	
complexes	 in	a	row.	The	AB	combination,	where	 the	complexes	are	canted	away	
from	each	 other,	 is	 strongly	 favored	 for	‐PHEN.	Thus,	 the	 exothermic	 enthalpy	
observed	close	 to	saturation	can	mainly	be	ascribed	to	AB‐duplets	 forming	ACB‐
triplets.	A	 similar	 interpretation	will	hold	also	 for	 the	‐complexes.	We	propose	
that	 steric	 and/or	 electrostatic	 repulsion	 between	 the	 phenanthroline	 or	
bipyridine	 ligands	account	 for	the	anti‐cooperativity	when	complexes	are	closely	
packed,	whereas	we	believe	that	the	cooperativity	observed	for	complexes	canted	
away	 from	 their	 neighbor	 is	 an	 effect	 of	 allosteric	 widening	 of	 the	 groove	 and	
favourable	interactions	between	the	phenantrolines/bipyridines	and	the	DNA.	
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Table	4.4.	 Intrinsic	binding	 constants	K,	 cooperativity	parameters	 y,	and	binding	 site	
sizes	n	for	binding	of	dppz	complexes	to	AT‐DNA.	
Complex	 K	(106	M‐1)	 yAB	 yAC/CB	 yCC	 nA/B	 nC	
‐PHEN	 1.1	 56	 6	 0.01	 2	 1.8	
‐BPY	 1.3	 0.3	 0.6	 0.2	 2	 1.8	
‐PHEN	 0.2	 8	 9	 0.05	 2	 1.8	
‐BPY	 0.2	 10	 9	 0.05	 1.85	 1.65	
	
	
Table	4.5.	Thermodynamic	data	for	the	intrinsic	binding	at	20	°C.	
Complex	 G	(kJ	mol‐1)	 H	(kJ	mol‐1)	 S	(J	K‐1	mol‐1)	 Cp	(J	K‐1	mol‐1)	
‐	PHEN	 ‐33.9	 7.4	 140	 ‐570	
‐	BPY	 ‐34.3	 4.5	 130	 ‐670	
‐	PHEN	 ‐29.8	 7.2	 130	 ‐450	
‐BPY	 ‐29.8	 10.9	 140	 ‐310	
	
	
	
Comparison	of	 the	relative	contributions	of	H	 and	S	 to	G	 in	Table	4.5	shows	
that	the	intrinsic	binding	is	entropically	driven.	This	indicates	that	desolvation	of	
hydrophobic	 surfaces	 play	 an	 important	 role	 for	 binding	 affinity,	 which	 is	 also	
supported	 by	 the	 negative	 Cp.	 Altogether,	 these	 results	 clearly	 show	 that	
complex‐complex	 interactions	have	 great	 influence	on	 the	 intercalation	of	 dppz‐	
complexes	 into	 AT‐DNA	 and	 it	 is	 likely	 that	 these	 effects	 are	 present	 also	 for	
threading	 intercalating	 complexes.	 Cooperativity	 may	 explain	 the	 slow	
redistribution	of	threaded	complexes	along	the	DNA	polymer	and	the	observation	
of	bi‐exponential	dissociation	kinetic	traces.73‐75	
	
Figure	4.13	shows	a	comparison	of	ITC	data	for	‐PHEN	titrated	into	AT‐	and	ct‐
DNA	at	25	C.	It	appears	from	Figure	4.13	that	intercalation	is	more	endothermic	
and	 the	 cooperativity	 less	 pronounced	 for	 ct‐DNA,	 which	 is	 consistent	 with	 the	
previous	report	by	Haq	et	al.126	A	more	endothermic	interaction	enthalpy	may,	at	
least	partly,	explain	the	lower	affinity	for	ct‐DNA	compared	with	AT‐DNA,	and	the	
absence	 of	 the	 strong	 exothermic	 enthalpy	 close	 to	 saturation	 suggests	 that	 the	
complexes	are	not	as	densely	packed	on	ct‐DNA.	Although	 the	data	presented	 in	
Figure	 4.13	 is	 only	 preliminary,	 it	 clearly	 shows	 that	 the	 complex‐complex	
interactions	of	‐PHEN	differs	depending	on	the	type	of	DNA.	Such	interactions	in	
the	bound	state	may	be	of	importance	also	for	threading	intercalation	ruthenium	
complexes,	and	may	contribute	to	the	AT‐selectivity	of	these	compounds.	
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Figure	4.13.	ITC	data	for	titration	of	‐PHEN	into	ct‐	(■)	and	AT‐DNA	(●)	at	25.	
4.5 Cell	Localization	and	Uptake	
All	 the	 DNA	 studies	 discussed	 above	 have	 been	 performed	 in	 simple	 systems	
containing	only	DNA	and	ruthenium	complex	in	sodium	chloride	solution,	and	due	
to	 the	 relatively	 few	 cell	 studies	 on	 binuclear	 ruthenium	 polypyridyl	 complexes	
little	 is	 known	 about	 their	 interactions	 with	 cells.67,	 71,	 127‐129	 Therefore,	 if	 the	
complexes	 are	 to	 be	 of	 any	 biological	 interest,	 it	 is	 of	 great	 importance	 to	
investigate	how	the	complexes	behave	 inside	cells	where	 they	encounter	a	much	
more	complex	milieu	due	to	the	presence	of	other	biomolecules.	For	this	work	it	is	
of	 particular	 importance	 to	 confirm	 that	DNA	binding	 can	 occur	 inside	 cells,	 but	
from	a	more	general	point	of	view	it	is	also	interesting	to	investigate	other	aspects	
of	the	interactions	with	living	cells,	such	as	uptake	and	toxicity.		
 
Since	 both	 the	meta‐	 and	para‐isomers	 of	2	 (here	 denoted	m	 and	p)	 are	 highly	
luminescent	 in	both	polar	and	non‐polar	environments	and	their	quantum	yields	
are	rather	 insensitive	to	 the	environment,	 these	complexes	are	suitable	as	model	
compounds	 for	studies	of	cellular	uptake	and	 localization	of	binuclear	ruthenium	
complexes.	Figure	4.14	shows	confocal	 laser	scanning	microscopy	 images	of	cells	
that	have	been	incubated	1	h	with	5	M	‐m.	As	seen	by	the	punctuate	staining	of	
the	 cytosol,	 the	 complex	 is	 readily	 internalized	already	at	 this	 low	concentration	
and	the	uptake	mechanism	is	probably	endocytosis	as	the	complex	appears	to	be	
localized	in	endosomes.	An	endocytotic	uptake	mechanism	is	further	supported	by	
the	fact	that	no	uptake	was	observed	when	the	same	experiment	was	performed	at	
4°C,	 where	 energy	 dependent	 mechanisms	 such	 as	 endocytosis	 are	 inhibited.	
Experiments	on	the	other	 isomers	yielded	similar	results.	Uptake	via	endocytosis	
has	 previously	 been	 observed	 for	 [‐C4(cpdppz)2(phen)4Ru2]4+,127	 but	 other	
mechanisms	has	been	proposed	for	other	binuclear	ruthenium	complexes.71,	128	Co‐
staining	with	 the	 dead	 cell	marker	 Sytox	 Green	 showed	 that	 the	 concentrations	
used	for	the	uptake	studies	are	non‐toxic	to	the	cells,	and	it	should	also	be	noted
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Figure	4.14.	Representative	confocal	laser	scanning	microscopy	images	of	live	CHO‐K1	
cells	after	1	h	 incubation	with	‐m	(5	μM)	at	a)	37	°C	and	c)	4	°C.	b)	and	d)	are	the	
corresponding	transmission	images.	Scale	bars	are	20	μm.	
	
that	 these	 concentrations	 are	 significantly	 lower	 than	 the	 ones	 used	 for	 cell	
staining	with	other	binuclear	ruthenium	complexes.71,	128‐129	
	
The	 cellular	 localization	 of	 the	 complexes	 was	 also	 investigated	 in	 fixed	 cells,	
where	the	cell	membrane	has	been	permeabilized	with	cold	methanol	to	allow	free	
passage	 of	 the	 complexes	 into	 the	 cytosol.	 As	 seen	 in	 Figure	 4.15,	 the	 staining	
pattern	 in	 fixed	 cells	 is	 very	 different	 from	 that	 in	 live	 cells	 for	 all	 four	 isomers,	
indicating	that	the	staining	of	the	endosomes	in	 live	cells	 is	due	to	difficulties	for	
the	 complexes	 to	 escape	 the	 membrane	 enclosed	 vesicles	 rather	 than	 an	 actual	
preference	for	them.	The	affinity	for	various	cellular	components	appears,	at	least	
for	 the	 investigated	 complexes,	 to	 be	more	 sensitive	 to	 the	 chirality	 around	 the	
ruthenium	 center	 than	 complex	 structure,	 with	 the	 ‐enantiomers	 displaying	
intense	 emission	 inside	 the	 nucleus	while	 the	‐enantiomers	 stain	 the	 cytosol	
and	the	nucleoli.	This	shows	that	chirality	is	an	important	factor	to	consider	when	
designing	molecules	targeting	cellular	components.	Both	enantiomers	also	bind	to	
membrane	structures,	but	these	interactions	seem	to	be	less	sensitive	to	chirality.	
	
Cell	 studies	 have	 also	 been	 performed	 for	 ‐1,	 ‐3	 and	 ‐4	 to	 investigate	
whether	threading	intercalation	occurs	also	in	cells.	None	of	the	complexes	could	
be	 detected	 inside	 live	 cells	 after	 1	 h	 incubation	 with	 5	 M	 complex,	 but	 in	
resemblance	with	 the	other	 binuclear	 complexes	 they	 are	 probably	 taken	up	 via	
endocytosis	and	trapped	in	endosomes	where	they	are	not	emissive.	After	addition	
of	methanol	 to	 the	 cells,	 which	 kills	 them	 and	 also	 permeabilizes	 the	 endosome	
membranes,	 staining	of	 the	cells	 slowly	appears	 (Figure	4.16).	The	effect	 is	most	
pronounced	 for	 ‐4,	 which	 after	 3	 h	 at	 37°C	 stains	 the	 nucleus	 and	 nucleoli,	
indicating	that	‐4	binds	DNA	and	perhaps	also	RNA	by	threading	intercalation.	
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Figure	4.15.	Representative	confocal	 laser	scanning	microscopy	 images	of	a)	‐m,	b)	
‐m,	c)	‐p,	and	d)	‐p	in	fixed	cells.	Cells	were	fixed	with	methanol	(‐20°C,	15	min)	
and	incubated	4	h	with	5	μM	ruthenium	complex	before	imaging.	Scale	bars	are	10	μm.	
	
		
Figure	4.16.	Confocal	laser	scanning	microscopy	images	of	a)	‐1,	b)	‐3	and	c)	‐4	
in	dead	 cells.	Live	 cells	were	 incubated	1	h	with	5	M	 complex,	and	 then	 rinsed	once	
before	a	 few	drops	of	MeOH	was	added	 to	kill	 the	cells.	Staining	of	 the	cells	appeared	
slowly,	and	images	were	taken	after	approximately	3	h	incubation	at	37	°C.	
 
‐3	exhibits	a	similar	staining	pattern,	but	 the	 intensity	 is	much	weaker,	which	
could	 be	 due	 to	 that	 threading	 of	 3	 is	 much	 slower	 and	 more	 AT‐selective	
compared	with	4.	Surprisingly,	‐1	displays	a	more	diffuse	staining	than	the other 
two complexes, where emission is detected also in the cytosol. The intensity is very 
weak also for -1. Similar results were obtained when adding complex to already 
fixed cells, except that -3 now displays a more diffuse staining. Although these are 
only preliminary results, they show that threading intercalation probably is possible also 
in cells, but that the reaction is very slow as expected. In resemblance with 2, uptake 
appears to occur via endocytosis, and endosomal escape may be a potential problem that 
has to be solved for any biological use.  
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In	 this	 thesis	 the	 DNA	 binding	 properties	 of	 several	 new	 ruthenium	 complexes	
have	been	investigated,	which	has	resulted	in	the	discovery	of	three	new	threading	
intercalators:	 [‐dppzip(phen)4Ru2]4+,	 [‐bidppze(phen)4Ru2]4+	 and	 [Ru(phen)2‐
10,13‐di(2’‐thienyl)dppz]2+.	Comparison	of	the	new	binuclear	complexes	with	the	
previously	 studied	 [‐bidppz(phen)4Ru2]4+	 has	 lead	 to	 several	 conclusions	
regarding	 the	 effect	 of	 complex	 structure	 on	 threading	 intercalation	 ability.	 In	
particular	it	has	been	shown	that	a	shorter	bridging	ligand	results	in	increased	AT‐
selectivity	but	reduced	binding	constant,	whereas	elongation	of	the	bridging	ligand	
has	 the	 opposite	 effects.	 Studies	 on	 the	 four	 stereoisomers	 of	 [‐
dppzip(phen)4Ru2]4+	 revealed	 ‐conformation	 on	 the	 dppz‐half	 and	 ‐
conformation	 on	 the	 ip‐half	 to	 be	 the	 optimal	 geometries,	 showing	 that	 the	
structural	 requirements	 are	 different	 for	 the	 two	 grooves.	 The	 fact	 that	 the	 two	
structural	 isomers	 of	 [‐bipb(phen)4Ru2]4+	 do	 not	 bind	 DNA	 by	 threading	
intercalation	 suggests	 that	 increased	 flexibility	 is	 not	 beneficial	 for	 this	 type	 of	
binding,	 though	 it	 should	 be	 kept	 in	mind	 that	 the	 bipb	 complexes	 have	 smaller	
aromatic	 ring	 systems	 than	 the	 dppz	 complexes	which	 could	make	 intercalation	
less	 favorable	 for	 the	 former	 ones.	 To	 date,	 all	 reported	 threading	 intercalating	
ruthenium	 complexes	 contain	 at	 least	 one	 dppz‐moiety,	 suggesting	 that	 this	
structure	plays	an	important	role	for	the	DNA	interaction.		
 
Despite	 these	 new	 insights	 regarding	 the	 structural	 requirements	 for	 threading	
intercalation	of	binuclear	ruthenium	complexes	there	is	still	much	to	learn	to	fully	
understand	 this	 type	 of	 binding.	 Considering	 the	 structural	 diversity	 of	 known	
threading	intercalators	(Figure	2.4)	it	would	be	interesting	to	do	more	systematic	
studies	 also	 on	 other	 types	 of	 threading	 compounds	 in	 order	 to	 generalize	 the	
results.	 For	 example,	 [‐dppzip(phen)4Ru2]4+	 appears	 to	 be	 just	 at	 the	 border	 of	
being	 capable	 of	 threading	 intercalation	 with	 dissociation	 rate	 constants	
significantly	 larger	 than	 for	 the	parent	 complex	 [‐bidppz(phen)4Ru2]4+,	which	 is	
thought	to	be	an	effect	of	the	shorter	bridging	ligand.	Yet,	nogalamycin,	where	the	
distance	 between	 the	 bulky	 substituents	 is	 even	 shorter,	 displays	 dissociation	
rates	 comparable	 to	 those	 of	 [‐bidppz(phen)4Ru2]4+	 suggesting	 that	 there	 are	
other	factors	than	just	bridging	ligand	length	involved.6‐7	
	
One	 of	 the	 new	 complexes,	 [‐dppzip(phen)4Ru2]4+,	 display	 a	 remarkable	 AT‐
selectivity,	which	is	promising	for	targeting	AT‐rich	DNA,	for	example	in	parasites.	
However,	in	order	to	target	specific	genes	the	selectivity	has	to	be	increased	even	
further.	A	possible	strategy	to	achieve	this	and	still	maintain	the	slow	dissociation	
5 CONCLUDING	REMARKS
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could	be	to	attach	sequence	recognizing	moieties,	such	as	the	hairpin	polyamides	
developed	by	Dervan	and	co‐workers,20,	23‐24	to	threading	intercalating	complexes.	
An	 advantage	 of	 threading	 intercalating	 compounds	 compared	 with	 other	
synthetic	DNA	binders	is	that	the	minor	groove	can	be	used	for	gene	recognition	to	
block	 DNA	 interactions	 also	 in	 the	 major	 groove.	 There	 are	 examples	 in	 the	
literature	 where	 oligonucleotides	 and	 peptides	 have	 been	 attached	 to	 dppz	 and	
bipyridine	 ligands	 of	 ruthenium	 complexes,	 respectively,	 showing	 that	 there	 are	
synthetic	methods	to	attach	such	moieties	to	polypyridyl	ligands.120,	130‐133	Grimm	
et	al.	have	also	reported	sequence	specific	threading	intercalation	into	duplex	DNA	
by	triplex	formation	of	oligonucleotide	tethered	[Ru(phen)2dppz]2+.120		
	
Studies	on	dead	cells	with	permeabilized	membranes	show	that	threading	occurs	
also	 in	 the	 complex	milieu	 inside	 cells	 demonstrating	 the	 biological	 relevance	 of	
these	complexes.	However,	in	live	cells	the	complexes	appear	to	be	internalized	via	
endocytosis	where	they	remain	trapped	in	the	endosomes,	which	is	a	problem	that	
needs	 to	 be	 addressed	 if	 the	 complexes	 are	 to	 be	 used	 for	 any	 biological	
applications.	 Nuclear	 localization	 could	 be	 enhanced	 by	 attachment	 of	 peptide	
constructs	to	the	complexes	as	previously	described	by	Barton	and	co‐workers.131‐
132	 Also,	 increased	 lipofilicity	 of	 the	 complexes	 may	 enhance	 membrane	
penetration.134‐136	 For	 this	 purpose,	 the	 mononuclear	 10,13‐substituted	 dppz	
complexes	may	serve	as	a	starting	point	for	design	of	new	threading	intercalators	
with	reduced	charge,	as	studies	on	this	type	of	complexes	have	shown	that	reduced	
charge	 can	 be	 compensated	 for	 by	 structural	 changes	 to	 maintain	 the	 slow	
dissociation.	Although	all	three	binuclear	threading	complexes	stain	the	nucleus	as	
expected	 for	 DNA	 binding	 compounds,	 [‐dppzip(phen)4Ru2]4+	 and	 [‐
bidppze(phen)4Ru2]4+	 display	 distinct	 staining	 also	 of	 the	 nucleoli	 while	 [‐
bidppz(phen)4Ru2]4+	displays	diffuse	staining	of	 the	cytosol.	Thus,	 the	complexes	
appear	 to	 interact	 also	 with	 other	 cellular	 components	 than	 DNA,	 showing	 that	
there	 is	a	need	to	 further	 investigate	 the	preference	 for	DNA	in	comparison	with	
other	 biomolecules	 such	 as	 RNA	 to	 fully	 understand	 the	 factors	 controlling	
selectivity.		
	
The	rare	and	charged	ruthenium	ion	may	seem	as	an	odd	choice	for	development	
of	DNA	binding	molecules	 for	 therapeutical	purposes.	However,	 the	primary	goal	
of	 this	 thesis	 has	 not	 been	 to	 develop	 drugs	 ready	 for	 therapeutial	 use	 but	 to	
increase	 the	 understanding	 of	 the	 relationship	 between	molecular	 structure	 and	
threading	 intercalation	 properties.	 For	 this	 purpose	 ruthenium	 is	 an	 excellent	
choice	 since	 it	 enables	 systematic	 variations	 of	 the	 structure	 and	 the	 resulting	
complexes	 are	 stable	 and	 easily	 obtained	 in	 their	 pure	 enantiomeric	 forms.	 The	
results	 show	 the	 potential	 of	 threading	 intercalating	 compounds	 as	 sequence	
specific	 DNA	 binding	 drugs	 and	 the	 new	 insights	 regarding	 the	 structural	
requirements	 for	 this	 type	of	binding	may	hopefully	 contribute	 to	design	of	new	
and	 better	 threading	 compounds	 in	 the	 future.	 The	 ruthenium	 ions	 could	 for	
example	be	substituted	for	the	more	abundant	iron	ion	or	a	monovalent	metal	to	
reduce	the	charge.	Metal‐free	compounds	with	protonated	groups	such	as	amines	
47 
 
is	 also	 a	 possibility.	 Recently,	 two	 ruthenium	 anticancer	 agents	 have	 reached	
clinical	trials.66	Although	these	complexes	are	structurally	very	different	from	the	
ones	studied	here,	this	shows	that	the	idea	of	ruthenium	based	drugs	is	not	so	far‐
fetched	after	all,	motivating	further	studies	also	on	ruthenium	complexes.	The		AT‐
specific	[‐dppzip(phen)4Ru2]4+	is	particularly	interesting	in	the	context	of	parasite	
diseases,	 but	 it	 should	 be	 kept	 in	 mind	 that	 there	 are	 many	 other	 factors	 in	
addition	to	the	DNA	binding	properties	 that	determine	the	therapeutical	use	of	a	
compound.			
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